-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AIIhhuX+0ZvY3Jdac2nGZSzGUZJDPG767bABI0T8WX1LcU/SAB7KEeO6sS6kw/VB 1XUCAH+S3Ie1ZAUiuboIYA== 0001021408-02-013915.txt : 20021113 0001021408-02-013915.hdr.sgml : 20021113 20021113155221 ACCESSION NUMBER: 0001021408-02-013915 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020930 FILED AS OF DATE: 20021113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHIPPAC INC CENTRAL INDEX KEY: 0001093779 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 770463048 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-31173 FILM NUMBER: 02820023 BUSINESS ADDRESS: STREET 1: 47400 KATO ROAD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5109798000 MAIL ADDRESS: STREET 1: 47400 KATO ROAD CITY: FREMONT STATE: CA ZIP: 94538 10-Q 1 d10q.htm FORM 10-Q FOR PERIOD ENDED 09/30/2002 Form 10-Q for period ended 09/30/2002
Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
(Mark One)
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
   
 
For the quarterly period ended September 30, 2002.
 
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
   
 
For the transition period from                              to                             .
 
Commission file number 000-31173
 
 
ChipPAC, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
  
77-0463048
(State or Other Jurisdiction of
Incorporation or Organization)
  
(I.R.S. Employer
Identification No.)
 
47400 Kato Road, Fremont, California 94538
(Address of Principal Executive Offices, Zip Code)
 
Registrant’s Telephone Number, Including Area Code (510) 979-8000
 
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
 
Class
  
Outstanding as of November 1, 2002
Class A common stock, $.01 par value
  
94,030,906
Class B common stock, $.01 par value
  
None
 
 

Table of Contents
TABLE OF CONTENTS
 
              
Page
PART I
   
FINANCIAL INFORMATION
     
    
Item 1.
   
Financial Statements
     
            
3
            
4
            
5
            
6
    
Item 2.
      
19
    
Item 3.
      
22
    
Item 4.
      
22
PART II
   
OTHER INFORMATION
     
    
Item 1.
      
23
    
Item 2.
      
23
    
Item 3.
      
23
    
Item 4.
      
23
    
Item 5.
      
23
    
Item 6.
      
23
       
28
       
29

2

Table of Contents
 
ChipPAC, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
(Unaudited)
 
    
September 30,
2002
     
December 31,
2001
  
ASSETS:
                  
Current assets:
                  
Cash and cash equivalents
   
$
96,337
 
   
$
41,872
 
Accounts receivable, less allowance for doubtful accounts of $384 and $449
   
 
37,883
 
   
 
32,034
 
Inventories
   
 
16,033
 
   
 
12,481
 
Prepaid expenses and other current assets
   
 
6,102
 
   
 
4,515
 
    
  
Total current assets
   
 
156,355
 
   
 
90,902
 
Property, plant and equipment, net
   
 
328,596
 
   
 
304,650
 
Other assets
   
 
34,528
 
   
 
35,163
 
    
  
Total assets
   
$
519,479
 
   
$
430,715
 
    
  
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
                  
Current liabilities:
                  
Revolving loans
   
$
50,000
 
   
$
50,000
 
Accounts payable
   
 
35,066
 
   
 
31,045
 
Accrued expenses and other current liabilities
   
 
27,811
 
   
 
27,838
 
    
  
Total current liabilities
   
 
112,877
 
   
 
108,883
 
Long-term debt
   
 
217,887
 
   
 
283,627
 
Convertible subordinated note
   
 
50,000
 
   
 
50,000
 
Other long-term liabilities
   
 
16,227
 
   
 
11,431
 
    
  
Total liabilities
   
 
396,991
 
   
 
453,941
 
    
  
Stockholders’ equity (deficit):
                  
Common stock, Class A—par value $0.01 per share; 250,000,000 shares authorized, 94,024,000 and 69,404,000 shares issued and outstanding at September 30, 2002 and December 31, 2001, respectively
   
 
940
 
   
 
694
 
Common stock, Class B—par value $0.01 per share; 250,000,000 shares authorized, no shares issued or outstanding at September 30, 2002 and December 31, 2001
   
 
—  
 
   
 
—  
 
Additional paid in capital
   
 
276,878
 
   
 
110,043
 
Receivable from stockholders
   
 
(480
)
   
 
(985
)
Accumulated other comprehensive income
   
 
9,169
 
   
 
9,169
 
Accumulated deficit
   
 
(164,019
)
   
 
(142,147
)
    
  
Total stockholders’ equity (deficit)
   
 
122,488
 
   
 
(23,226
)
    
  
Total liabilities and stockholders’ equity (deficit)
   
$
519,479
 
   
$
430,715
 
    
  
 
The accompanying notes are an integral part of these financial statements.

3

Table of Contents
 
ChipPAC, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
 
    
For the Three Months Ended
September 30,
     
For the Nine Months Ended September 30,
  
    
2002
     
2001
     
2002
     
2001
  
Revenue
   
$
94,659
 
   
$
74,662
 
   
$
270,958
 
   
$
251,894
 
Cost of revenue
   
 
78,699
 
   
 
72,637
 
   
 
227,679
 
   
 
226,688
 
    
  
  
  
Gross profit
   
 
15,960
 
   
 
2,025
 
   
 
43,279
 
   
 
25,206
 
    
  
  
  
Operating expenses:
                                    
Selling, general and administrative
   
 
9,362
 
   
 
5,877
 
   
 
28,982
 
   
 
22,639
 
Research and development
   
 
2,550
 
   
 
3,333
 
   
 
7,258
 
   
 
10,683
 
Restructuring and other charges
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
2,962
 
    
  
  
  
Total operating expenses
   
 
11,912
 
   
 
9,210
 
   
 
36,240
 
   
 
36,284
 
    
  
  
  
Operating income (loss)
   
 
4,048
 
   
 
(7,185
)
   
 
7,039
 
   
 
(11,078
)
Non-operating (income) expenses:
                                    
Interest expense
   
 
7,691
 
   
 
9,445
 
   
 
24,479
 
   
 
27,733
 
Interest income
   
 
(242
)
   
 
(167
)
   
 
(455
)
   
 
(389
)
Foreign currency (gains) losses
   
 
(547
)
   
 
16
 
   
 
860
 
   
 
(239
)
Other income, net
   
 
(175
)
   
 
(38
)
   
 
(478
)
   
 
(267
)
    
  
  
  
Total non-operating expenses
   
 
6,727
 
   
 
9,256
 
   
 
24,406
 
   
 
26,838
 
    
  
  
  
Loss before income taxes
   
 
(2,679
)
   
 
(16,441
)
   
 
(17,367
)
   
 
(37,916
)
Provision for (benefit from) income taxes
   
 
500
 
   
 
—  
 
   
 
1,500
 
   
 
(4,295
)
Loss before extraordinary item
   
 
(3,179
)
   
 
(16,441
)
   
 
(18,867
)
   
 
(33,621
)
    
  
  
  
Loss from early extinguishment of debt, net of related income tax of $0
   
 
—  
 
   
 
—  
 
   
 
3,005
 
   
 
—  
 
    
  
  
  
Net loss
   
$
(3,179
)
   
$
(16,441
)
   
$
(21,872
)
   
$
(33,621
)
    
  
  
  
Loss per share before extraordinary item
                                    
Basic
   
$
(0.03
)
   
$
(0.24
)
   
$
(0.22
)
   
$
(0.49
)
Diluted
   
$
(0.03
)
   
$
(0.24
)
   
$
(0.22
)
   
$
(0.49
)
Extraordinary item
                                    
Basic
   
$
—  
 
   
$
—  
 
   
$
(0.04
)
   
$
—  
 
Diluted
   
$
—  
 
   
$
—  
 
   
$
(0.04
)
   
$
—  
 
Net loss per share
                                    
Basic
   
$
(0.03
)
   
$
(0.24
)
   
$
(0.26
)
   
$
(0.49
)
Diluted
   
$
(0.03
)
   
$
(0.24
)
   
$
(0.26
)
   
$
(0.49
)
Weighted average shares used in per share calculation:
                                    
Basic
   
 
93,421
 
   
 
68,889
 
   
 
85,166
 
   
 
68,714
 
Diluted
   
 
93,421
 
   
 
68,889
 
   
 
85,166
 
   
 
68,714
 
 
The accompanying notes are an integral part of these financial statements.

4

Table of Contents
 
ChipPAC, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
    
For the Nine Months Ended September 30,
  
    
2002
     
2001
  
Cash flows from operating activities:
                  
Net loss
   
$
(21,872
)
   
$
(33,621
)
Adjustments to reconcile net loss to net cash provided by (used) in operating activities:
                  
Depreciation and amortization
   
 
42,947
 
   
 
44,177
 
Amortization of debt issuance cost
   
 
1,832
 
   
 
1,522
 
Loss from early debt extinguishment
   
 
3,005
 
   
 
—  
 
Foreign currency (gains) losses
   
 
860
 
   
 
(239
)
(Gain) loss on sale of equipment
   
 
(65
)
   
 
20
 
Changes in assets and liabilities:
                  
Accounts receivable
   
 
(5,849
)
   
 
11,685
 
Inventories
   
 
(3,552
)
   
 
10,333
 
Prepaid expenses and other current assets
   
 
(1,587
)
   
 
(7,320
)
Other assets
   
 
(7,401
)
   
 
—  
 
Accounts payable
   
 
4,021
 
   
 
(26,095
)
Accrued expenses and other current liabilities
   
 
(27
)
   
 
(19,953
)
Other long-term liabilities
   
 
4,796
 
   
 
159
 
    
  
Net cash provided by (used) in operating activities
   
 
17,108
 
   
 
(19,332
)
    
  
Cash flows from investing activities:
                  
Acquisition of property, plant and equipment
   
 
(57,999
)
   
 
(33,976
)
Proceeds from sale of equipment
   
 
86
 
   
 
532
 
Malaysian acquisition, net of cash and cash equivalents acquired
   
 
(5,873
)
   
 
(4,546
)
    
  
Net cash used in investing activities
   
 
(63,786
)
   
 
(37,990
)
    
  
Cash flows from financing activities:
                  
Proceeds from revolving loans and other line of credit
   
 
105,596
 
   
 
14,179
 
Repayment of revolving loans and other line of credit
   
 
(105,596
)
   
 
—  
 
Proceeds from other loans
   
 
16,700
 
   
 
60,703
 
Debt issuance cost
   
 
(703
)
   
 
—  
 
Repayment of long-term debt
   
 
(82,440
)
   
 
(14,773
)
Repayment of notes from stockholders
   
 
505
 
   
 
—  
 
Proceeds from common stock issuance
   
 
167,105
 
   
 
4,271
 
Repurchase of non vested early exercise of stock options
   
 
(24
)
   
 
—  
 
    
  
Net cash provided by financing activities
   
 
101,143
 
   
 
64,380
 
    
  
Net increase (decrease) in cash
   
 
54,465
 
   
 
7,058
 
Cash and cash equivalents at beginning of period
   
 
41,872
 
   
 
18,850
 
    
  
Cash and cash equivalents at end of period
   
$
96,337
 
   
$
25,908
 
    
  
 
The accompanying notes are an integral part of these financial statements.

5

Table of Contents
ChipPAC, Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Quarter Ended September 30, 2002
(Unaudited)
 
Note 1:    Interim Statements
 
In the opinion of management of ChipPAC, Inc. (“ChipPAC” or the “Company”), the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial information included therein. This financial data should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2001 included in ChipPAC’s 2001 Annual Report on Form 10-K.
 
The results of operations for interim periods are not necessarily indicative of the results of operations that may be expected for any other period or the fiscal year which ends on December 31, 2002. The interim period ended on September 29, 2002, the Sunday nearest September 30th.
 
Recent Accounting Pronouncements
 
In June 2001, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 143, “Accounting for Asset Retirement Obligations”. SFAS No. 143 requires that the fair value of a liability for an asset retirement obligation be realized in the period which it is incurred if a reasonable estimate of fair value can be made. Companies are required to adopt SFAS No. 143 for fiscal years beginning after June 15, 2002, but early adoption is encouraged. The Company has not yet determined the impact this standard will have on its financial position and results of operations, although it does not anticipate that the adoption of this standard will have a material impact on the Company’s financial position or results of operations.
 
In May 2002, the FASB issued SFAS No. 145, “Rescission of SFAS Nos. 4, 44, and 64, Amendment of SFAS No. 13, and Technical Corrections”. Among other things, SFAS No. 145 rescinds various pronouncements regarding early extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business and Extraordinary, Unusual and Infrequently Occurring Events and Transactions” are met. SFAS No. 145 provisions regarding early extinguishment of debt are generally effective for fiscal years beginning after May 15, 2002. Upon adoption of SFAS No. 145, the Company has to reclassify any gain or loss on extinguishment of debt that was classified as an extraordinary item in prior periods presented that does not meet the criteria in APB Opinion No. 30 for classification as an extraordinary item and show it within income from continuing operations.
 
In June 2002, the FASB issued SFAS No. 146, “Accounting for Exit or Disposal Activities”. SFAS No. 146 addresses significant issues regarding the recognition, measurement, and reporting of costs that are associated with exit and disposal activities, including restructuring activities that are currently accounted for under EITF No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring).” The scope of SFAS No. 146 also includes costs related to terminating a contract that is not a capital lease and termination benefits that employees who are involuntarily terminated receive under the terms of a one-time benefit arrangement that is not an ongoing benefit arrangement or an individual deferred-compensation contract. SFAS No. 146 will be effective for exit or disposal activities that are initiated after December 31, 2002 and early application is encouraged. We will adopt SFAS No. 146 during the first quarter of fiscal year 2003. The provisions of EITF No. 94-3 shall continue to apply for an exit activity initiated under an exit plan that met the criteria of EITF No. 94-3 prior to the adoption of SFAS No. 146. The effect on adoption of SFAS No. 146 will change on a prospective basis the timing of when restructuring charges are recorded from a commitment date approach to when the liability is incurred.

6

Table of Contents
ChipPAC, Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Quarter Ended September 30, 2002
(Unaudited)
 
Basis of Presentation
 
The financial statements have been prepared on a consolidated basis. The condensed consolidated financial statements include the accounts of ChipPAC, Inc. and its majority controlled and owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation.
 
Note 2:    Selected Balance Sheet Accounts
 
The components of inventories were as follows (in thousands):
 
    
September 30, 2002
   
December 31, 2001
Raw materials
   
$
12,392
   
$
7,949
Work in process
   
 
3,058
   
 
3,080
Finished goods
   
 
583
   
 
1,452
    
  
    
$
16,033
   
$
12,481
    
  
 
Other assets were comprised of the following (in thousands):
 
    
September 30, 2002
   
December 31, 2001
Deposits
   
$
5,592
   
$
1,603
Long-term employee loans
   
 
792
   
 
652
Debt issuance costs, net of amortization of $5,495 and $7,226
   
 
10,581
   
 
14,715
Intangible assets, net of amortization of $15,776 and $12,015
   
 
17,540
   
 
18,038
Other
   
 
23
   
 
155
    
  
    
$
34,528
   
$
35,163
    
  
 
Intangible assets balances as of September 30, 2002 are summarized as follows (in thousands):
 
    
Gross Assets
   
Accumulated Amortization
   
Net Assets
Intellectual property
   
$
15,182
   
$
4,431
   
$
10,751
Software and software development
   
 
13,787
   
 
7,853
   
 
5,934
Licenses
   
 
4,347
   
 
3,492
   
 
855
    
  
  
    
$
33,316
   
$
15,776
   
$
17,540
    
  
  
 
Amortization expense for intangible assets is summarized as follows (in thousands):
 
    
Three Months Ended September 30,
    
2002
   
2001
Intellectual property
   
$
535
   
$
495
Software and software development
   
 
659
   
 
597
Licenses
   
 
134
   
 
778
    
  
    
$
1,328
   
$
1,870
    
  

7

Table of Contents
 
Intangible assets are being amortized over estimated useful lives of three to seven years. Estimated future amortization expense is as follows (in thousands):
 
October 1, 2002 to December 31, 2002
   
$
1,181
2003
   
 
4,911
2004
   
 
4,029
2005
   
 
3,979
2006
   
 
2,353
2007
   
 
1,087
Thereafter
   
 
—  
    
Total
   
$
17,540
    
 
Accrued expenses and other liabilities were comprised of the following (in thousands):
 
    
September 30, 2002
   
December 31, 2001
Payroll and related items
   
$
15,651
   
$
9,696
Interest payable
   
 
4,791
   
 
10,954
Restructuring reserve
   
 
1,332
   
 
1,632
Other expenses
   
 
6,037
   
 
5,556
    
  
    
$
27,811
   
$
27,838
    
  
 
In the first and fourth quarters of 2001, ChipPAC’s management approved restructuring plans to realign its organization and reduce operating costs. These actions were designed to better align ChipPAC’s workforce and to reduce operating expenses. These plans were a combination of reductions in work force and employee furloughs. Accordingly, ChipPAC planned to reduce associated employee positions by approximately 554 and 197 worldwide in connection with the first and fourth quarter plans, respectively. Restructuring and related charges of $3.0 million and $3.3 million were expensed during the first and fourth quarters of 2001, respectively. The entire first quarter charge of $3.0 million was related to employee separations and furloughs. The fourth quarter charge was comprised of $1.8 million related to employee separations and $1.5 million of other charges for the forgiveness of loans to executive officers. During the quarter ended March 31, 2002, the Company utilized $0.3 million of the restructuring accrual and completed another 14 of the planned 751 employee separations. There were no changes to the components of accrued restructuring costs and amounts charged for restructuring during the quarters ended June 30, 2002 and September 30, 2002. Cumulatively, the Company has completed 568 of the planned 751 employee separations. ChipPAC expects to substantially complete the initiatives contemplated under the restructuring plans by December 31, 2002. The details of the accrued restructuring costs as of September 30, 2002 were as follows (in thousands):
 
    
Beginning Accrual
   
Utilization
     
December 31, 2001
   
Utilization
       
September 30, 2002
Employee separations
   
$
4,732
   
$
(3,100
)
   
$
1,632
   
$
(300
)
     
$
1,332
    
  
  
  
    
 
Note 3:    Line of credit and Other Bank Borrowings
 
Line of Credit
 
The Company has a revolving line of credit under our existing senior credit facilities for $50.0 million, of which the entire $50.0 million was outstanding as of September 30, 2002. In October 2002, the entire $50.0 million was repaid and the entire revolving line of credit is available for usage. In addition, the Korean subsidiary has established two separate lines of credit with Korean Exchange Bank and Cho Hung Bank, with credit limits of $10.2 million and $8.0 million, respectively. As of September 30, 2002, the Company had no outstanding borrowings against either of these lines of credit. Both agreements are subject to an annual review by Korean Exchange Bank and Cho Hung Bank, respectively, for the continued use of the credit line facility. The Company also has a line of credit available with Southern Bank Bhd. for $0.5 million. There were no outstanding borrowings on this credit line as of September 30, 2002.

8

Table of Contents
 
Other Bank Borrowings
 
The Company established a loan with Cho Hung Bank in 2002 providing for a loan of $16.7 million utilized for general corporate purposes. As of September 30, 2002, $16.7 million remained outstanding under the loan with an interest rate of 4.6%. The loan has a maturity date of April 22, 2004.
 
Note 4:    Common Stock Offering
 
On January 30, 2002, the Company sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, the Company sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option for $6.00 per share. In connection with these sales, the Company received net proceeds of approximately $63.9 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.5 million was used for general corporate purposes.
 
On May 30, 2002, the Company sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with these sales, the Company received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans and revolving loans. The remaining $49.2 million was used for general corporate purposes.
 
Sources and Use of Funds From Issuance of Common Stock
 
    
January Offering
     
May Offering
     
Totals
  
    
(in thousands)
  
Source of funds:
                           
Gross proceeds from issuance of common stock
   
$
68,554
 
   
$
105,000
 
   
$
173,554
 
Less: related issuance costs
   
 
(4,674
)
   
 
(5,830
)
   
 
(10,504
)
    
  
  
Net proceeds from issuance of common stock
   
$
63,880
 
   
$
99,170
 
   
$
163,050
 
    
  
  
Use of funds:
                           
Repayment of senior credit facilities
   
$
62,438
 
   
$
50,000
 
   
$
112,438
 
General corporate purposes
   
 
1,442
 
   
 
49,170
 
   
 
50,612
 
    
  
  
    
$
63,880
 
   
$
99,170
 
   
$
163,050
 
    
  
  
 
In June 2002, the Company utilized $50.0 million of the public offering proceeds to extinguish term loan A and the capital expenditure loan and substantially pay down term loan B under its senior credit facility. As a result, capitalized debt issuance costs of $3.0 million were written off and the expense is included in the results for the nine month period ended September 30, 2002 as an extraordinary item with no comparable results for the same period in 2001. There was no tax benefit for the write off because the costs were written off in a tax jurisdiction that provides no such benefit.
 
Note 5:    Acquisition of Malaysian Business
 
On June 30, 2000, the Company consummated the acquisition of Intersil’s packaging and test operations located in Kuala Lumpur, Malaysia, along with related intellectual property for approximately $71.5 million in cash and preferred stock.
 
The terms of the acquisition of the Malaysian business require the Company to pay until June 30, 2003 additional contingent incentive payments to Intersil based on the achievement of milestones with respect to the transfer of the seller’s packaging business. The Company records these contingent payments as additional purchase price if and when they are earned. In the event that Intersil were to achieve all of the milestones, Intersil would receive an additional sum of approximately $17.9 million in the aggregate. For the quarter ended September 30, 2002, the Company paid $1.7 million relating to the achievement of milestones and cumulatively $12.7 million of contingent incentive payments have been paid since the acquisition. Additionally, in 2001, $2.4 million of other purchase price adjustments were recorded based on the difference between the final closing balance sheet and the estimated closing balance sheet of the Malaysian business. As of September 30, 2002, deferred tax of $4.0 million has been recorded on all of these adjustments. This resulted in a further increase in non-current assets. These payments increased the effective purchase price and were allocated to non-current assets.

9

Table of Contents
 
There was no goodwill arising from the acquisition of the Malaysian business. The fair value of total assets and liabilities exceeded the purchase price by $56.2 million as of July 1, 2000. This amount reduced by the additional contingent incentive payments made as of September 30, 2002 have been allocated in full to non-current assets as summarized below:
 
Non-current assets
   
Estimated Fair Value
     
Excess of Fair Value of Acquired Net Assets Over Cost
     
Total Additional Purchase Price
   
Adjusted Fair Value
    
(in millions)
Land and buildings
   
$
27.9
     
$
(11.1
)
   
$
3.9
   
$
20.7
Plant and equipment
   
 
93.9
     
 
(36.9
)
   
 
13.0
   
 
70.0
Intellectual property
   
 
20.9
     
 
(8.2
)
   
 
2.2
   
 
14.9
    
    
  
  
    
$
142.7
     
$
(56.2
)
   
$
19.1
   
$
105.6
    
    
  
  
 
Note 6:    Earnings Per Share
 
SFAS No. 128 requires a reconciliation of the numerators and denominators of the basic and diluted per share computations. Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to stockholders (numerator) by the weighted average number of shares of common stock outstanding (denominator) during the period. Diluted EPS is computed using the weighted average number of shares of common stock and all potentially dilutive shares of common stock outstanding during the period. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and the if-converted method is used for determining the number of shares assumed issued from the conversion of the convertible subordinated notes.
 
As of September 30, 2002, there were options outstanding to purchase 6.5 million shares of Class A common stock with a weighted average exercise price of $4.13, which could potentially dilute basic EPS in the future, but were not included in diluted EPS as their effect would have been antidilutive. The Company also has outstanding the $50.0 million convertible subordinated notes which are convertible into approximately 5.0 million shares of Class A common stock at $9.96 per share but were not included in diluted EPS as their effect would also have been antidilutive. The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the periods presented below.
 
    
Three Months Ended
September 30, 2002
     
Three Months Ended
September 30, 2001
  
    
Net Loss
     
Shares
   
Per-Share Amount
     
Net Loss
     
Shares
   
Per-Share Amount
  
    
  
  
  
  
  
    
(In thousands, except per share amounts)
  
Basic EPS:
                                              
Loss before extraordinary item
   
$
(3,179
)
   
93,421
   
$
(0.03
)
   
$
(16,441
)
   
68,889
   
$
(0.24
)
Extraordinary item
   
 
—  
 
   
—  
   
 
—  
 
   
 
—  
 
   
—  
   
 
—  
 
Net loss per share
   
$
(3,179
)
   
93,421
   
$
(0.03
)
   
$
(16,441
)
   
68,889
   
$
(0.24
)
Diluted EPS:
                                              
Loss before extraordinary item
   
$
(3,179
)
   
93,421
   
$
(0.03
)
   
$
(16,441
)
   
68,889
   
$
(0.24
)
Extraordinary item
   
 
—  
 
   
—  
   
 
—  
 
   
 
—  
 
   
—  
   
 
—  
 
Net loss per share
   
$
(3,179
)
   
93,421
   
$
(0.03
)
   
$
(16,441
)
   
68,889
   
$
(0.24
)
 
    
Nine Months Ended
September 30, 2002
     
Nine Months Ended
September 30, 2001
  
    
Net Loss
     
Shares
   
Per-Share Amount
     
Net Loss
     
Shares
   
Per-Share Amount
  
    
(In thousands, except per share amounts)
  
Basic EPS:
                                              
Loss before extraordinary item
   
$
(18,867
)
   
85,166
   
$
(0.22
)
   
$
(33,621
)
   
68,714
   
$
(0.49
)
Extraordinary item
   
 
(3,005
)
   
85,166
   
 
(0.04
)
   
 
—  
 
   
—  
   
 
—  
 
Net loss per share
   
$
(21,872
)
   
85,166
   
$
(0.26
)
   
$
(33,621
)
   
68,714
   
$
(0.49
)
Diluted EPS:
                                              
Loss before extraordinary item
   
$
(18,867
)
   
85,166
   
$
(0.22
)
   
$
(33,621
)
   
68,714
   
$
(0.49
)
Extraordinary item
   
 
(3,005
)
   
85,166
   
 
(0.04
)
   
 
—  
 
   
—  
   
 
—  
 
Net loss per share
   
$
(21,872
)
   
85,166
   
$
(0.26
)
   
$
(33,621
)
   
68,714
   
$
(0.49
)

10

Table of Contents
 
Note 7:    Stock-Based Compensation
 
The Company has adopted the disclosure only provisions of SFAS No. 123. Accordingly, no compensation expense has been recognized for the Company’s stock option and purchase plan activity. If compensation expense had been determined based on the grant date fair value for awards during the nine month period ended September 30, 2002, in accordance with the provisions of SFAS No. 123, the Company’s net loss and loss per share would have been adjusted to the pro forma amounts indicated below:
 
      
Nine months ended September 30, 2002 (In thousands, except per share amounts)
  
Net loss as reported
     
$
(21,872
)
Pro forma net loss
     
 
(25,650
)
Loss per share as reported:
           
Basic
     
$
(0.26
)
Diluted
     
$
(0.26
)
Pro forma loss per share:
           
Basic
     
$
(0.30
)
Diluted
     
$
(0.30
)
 
In calculating pro forma compensation, the fair value of each stock option and stock purchase right is estimated on the date of grant using the Black-Scholes option-pricing model and the following weighted average assumptions:
 
      
Employee Stock Options September 30. 2002
       
Employee Stock Purchase Plan September 30, 2002
  
Dividend yield
     
None
 
     
None
 
Volatility
     
53.3
%
     
53.3
%
Risk-free interest rate
     
3.68
%
     
2.29
%
Expected lives (in years)
     
2–4
 
     
0.5
 
 
Note 8:    Contingent Liabilities
 
On June 30, 2000, the Company consummated the acquisition of Intersil’s packaging and test operations located in Kuala Lumpur, Malaysia, along with related intellectual property for approximately $71.5 million in cash and preferred stock.
 
The terms of the acquisition of the Malaysian business require the Company to pay until June 30, 2003 additional contingent incentive payments to Intersil based on the achievement of milestones with respect to the transfer of the seller’s packaging business, previously subcontracted by Intersil to third parties, to the Company. The Company records these contingent payments as additional purchase price if and when they are earned. In the event that Intersil were to achieve all of the milestones, Intersil would receive an additional sum of approximately $17.9 million in the aggregate. For the quarter ended September 30, 2002, the Company paid $1.7 million relating to the achievement of milestones and cumulatively $12.7 million of contingent incentive payments have been paid since the acquisition. These payments increased the effective purchase price and were allocated to non-current assets.
 
During the quarter ended June 30, 2002, an assessment of approximately $13.2 million was made by the Korean National Tax Administration (“NTA”) relating to withholding tax not collected and remitted related to the loan between our subsidiaries in Korea and Hungary. There were no further assessments made during the quarter ended September 30, 2002. Withholding on the transactions in question is not required by the prevailing tax treaty. The Company appealed the assessment through the Mutual Agreement Procedure (“MAP”) and believes that the assessment will be overturned. As of September 30, 2002, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a tax suspension of the proposed assessment until resolution of the MAP. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. The Company complied with the guarantee request on August 1, 2002.

11

Table of Contents
 
Note 9:    Supplemental Financial Statements of Guarantor/Non-Guarantor Entities
 
In connection with the recapitalization, in August 1999, ChipPAC International Company Limited, (“CP Int’l”), issued senior subordinated debt securities which are fully and unconditionally guaranteed, jointly and severally, on a senior subordinated basis, by the parent company, ChipPAC, Inc. (“CPI”) and by ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Korea Company Limited (“CPK”), ChipPAC Malaysia Sdn. Bhd. (“CPM”), ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company (the “Guarantor Subsidiaries”). All Guarantor Subsidiaries are wholly-owned direct or indirect subsidiaries of CPI. ChipPAC Shanghai Limited (“CPS”) did not provide guarantees (the “Non-Guarantor Subsidiary”). The following is consolidated financial information for CP Int’l CPI, and CPK, CPS, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company, segregated between the Guarantor and Non-Guarantor Subsidiaries.
 

12

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS
September 30, 2002
(In thousands)
(Unaudited)
 
    
Parent
Guarantor
CPI
     
Issuer
CP Int’l
     
Other
Guarantors
     
Non-
Guarantor
China
     
Eliminations
     
Consolidated
  
ASSETS
                                                      
Current assets:
                                                      
Cash and cash equivalents
   
$
27,603
 
   
$
50,243
 
   
$
16,539
 
   
$
1,952
 
   
$
—  
 
   
$
96,337
 
Intercompany accounts receivable
   
 
203,649
 
   
 
72,175
 
   
 
21,771
 
   
 
19,837
 
   
 
(317,432
)
   
 
—
 
Accounts receivable, net
   
 
18
 
   
 
2
 
   
 
37,799
 
   
 
64
 
   
 
—  
 
   
 
37,883
 
Inventories
   
 
—  
 
   
 
—  
 
   
 
12,286
 
   
 
3,747
 
   
 
—  
 
   
 
16,033
 
Prepaid expenses and other current assets
   
 
928
 
   
 
38
 
   
 
3,963
 
   
 
1,173
 
   
 
—  
 
   
 
6,102
 
    
  
  
  
  
  
Total current assets
   
 
232,198
 
   
 
122,458
 
   
 
92,358
 
   
 
26,773
 
   
 
(317,432
)
   
 
156,355
 
Property, plant and equipment, net
   
 
5,521
 
   
 
3,717
 
   
 
216,422
 
   
 
102,936
 
   
 
—  
 
   
 
328,596
 
Intercompany loans receivable
   
 
—  
 
   
 
352,500
 
   
 
—  
 
   
 
—  
 
   
 
(352,500
)
   
 
—  
 
Investment in subsidiaries
   
 
(60,364
)
   
 
—  
 
   
 
59,107
 
   
 
—  
 
   
 
1,257
 
   
 
—  
 
Other assets
   
 
3,700
 
   
 
7,766
 
   
 
22,418
 
   
 
644
 
   
 
—  
 
   
 
34,528
 
    
  
  
  
  
  
Total assets
   
$
181,055
 
   
$
486,441
 
   
$
390,305
 
   
$
130,353
 
   
$
(668,675
)
   
$
519,479
 
    
  
  
  
  
  
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
                                                      
Current liabilities:
                                                      
Intercompany accounts payable
   
$
533
 
   
$
160,090
 
   
$
133,172
 
   
$
23,638
 
   
$
(317,433
)
   
$
—  
 
Revolving loans
   
 
—  
 
   
 
50,000
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
50,000
 
Accounts payable
   
 
2,071
 
   
 
57
 
   
 
24,657
 
   
 
8,281
 
   
 
—  
 
   
 
35,066
 
Accrued expenses and other current liabilities
   
 
5,963
 
   
 
4,065
 
   
 
10,702
 
   
 
7,081
 
   
 
—  
 
   
 
27,811
 
Current portion of long-term debt
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—
 
   
 
—  
 
   
 
—  
 
    
  
  
  
  
  
Total current liabilities
   
 
8,567
 
   
 
214,212
 
   
 
168,531
 
   
 
39,000
 
   
 
(317,433
)
   
 
112,877
 
Long-term debt, less current portion
   
 
—  
 
   
 
201,187
 
   
 
16,700
 
   
 
—  
 
   
 
—  
 
   
 
217,887
 
Convertible subordinated note
   
 
50,000
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
50,000
 
Intercompany loans payable
   
 
—  
 
   
 
—  
 
   
 
318,500
 
   
 
34,000
 
   
 
(352,500
)
   
 
—  
 
Other long-term liabilities
   
 
—  
 
   
 
—  
 
   
 
16,227
 
   
 
—  
 
   
 
—  
 
   
 
16,227
 
    
  
  
  
  
  
Total liabilities
   
 
58,567
 
   
 
415,399
 
   
 
519,958
 
   
 
73,000
 
   
 
(669,933
)
   
 
396,991
 
    
  
  
  
  
  
Stockholders’ equity (deficit):
                                                      
Common stock
   
 
940
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
940
 
Additional paid in capital
   
 
276,878
 
   
 
81,689
 
   
 
20,692
 
   
 
115,093
 
   
 
(217,474
)
   
 
276,878
 
Receivable from stockholders
   
 
(480
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(480
)
Accumulated other comprehensive income
   
 
9,169
 
   
 
—  
 
   
 
8,705
 
   
 
464
 
   
 
(9,169
)
   
 
9,169
 
Accumulated deficit
   
 
(164,019
)
   
 
(10,647
)
   
 
(159,050
)
   
 
(58,204
)
   
 
227,901
 
   
 
(164,019
)
    
  
  
  
  
  
Total stockholders’ equity (deficit)
   
 
122,488
 
   
 
71,042
 
   
 
(129,653
)
   
 
57,353
 
   
 
1,258
 
   
 
122,488
 
    
  
  
  
  
  
Total liabilities and stockholders’ equity (deficit)
   
$
181,055
 
   
$
486,441
 
   
$
390,305
 
   
$
130,353
 
   
$
(668,675
)
   
$
519,479
 
    
  
  
  
  
  

13

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
Nine Months Ended September 30, 2002
(In thousands)
(Unaudited)
 
    
Parent Guarantor CPI
     
Issuer CP Int’l
     
Other Guarantors
     
Non- Guarantor China
     
Eliminations
     
Consolidated
  
Revenue
                                                      
Intercompany revenue
   
$
21,067
 
   
$
200
 
   
$
—  
 
   
$
51,080
 
   
$
(72,347
)
   
$
—  
 
Customer revenue
   
 
—  
 
   
 
—  
 
   
 
270,703
 
   
 
255
 
   
 
—  
 
   
 
270,958
 
    
  
  
  
  
  
    
 
21,067
 
   
 
200
 
   
 
270,703
 
   
 
51,335
 
   
 
(72,347
)
   
 
270,958
 
Cost of revenue
   
 
—  
 
   
 
120
 
   
 
253,259
 
   
 
46,647
 
   
 
(72,347
)
   
 
227,679
 
    
  
  
  
  
  
Gross profit
   
 
21,067
 
   
 
80
 
   
 
17,444
 
   
 
4,688
 
   
 
—  
 
   
 
43,279
 
Operating expenses:
                                                      
Selling, general and administrative
   
 
17,613
 
   
 
233
 
   
 
8,261
 
   
 
2,875
 
   
 
—  
 
   
 
28,982
 
Research and development
   
 
1,957
 
   
 
—  
 
   
 
5,301
 
   
 
—  
 
   
 
—  
 
   
 
7,258
 
    
  
  
  
  
  
Total operating expenses
   
 
19,570
 
   
 
233
 
   
 
13,562
 
   
 
2,875
 
   
 
—  
 
   
 
36,240
 
    
  
  
  
  
  
Operating income (loss)
   
 
1,497
 
   
 
(153
)
   
 
3,882
 
   
 
1,813
 
   
 
—  
 
   
 
7,039
 
Non-operating (income) expenses
                                                      
Inter-company interest expense
   
 
—  
 
   
 
—  
 
   
 
21,254
 
   
 
2,510
 
   
 
(23,764
)
   
 
—  
 
Interest expense
   
 
3,300
 
   
 
20,724
 
   
 
455
 
   
 
—  
 
   
 
—  
 
   
 
24,479
 
Interest income
   
 
(291
)
   
 
(22
)
   
 
(123
)
   
 
(19
)
   
 
—  
 
   
 
(455
)
Inter-company interest income
   
 
—  
 
   
 
(23,677
)
   
 
(87
)
   
 
—  
 
   
 
23,764
 
   
 
—  
 
Loss from investment in subsidiaries
   
 
20,362
 
   
 
—  
 
   
 
809
 
   
 
—  
 
   
 
(21,171
)
   
 
—  
 
Foreign currency loss
   
 
—  
 
   
 
—  
 
   
 
815
 
   
 
45
 
   
 
—  
 
   
 
860
 
Other (income) expenses, net
   
 
(5
)
   
 
—  
 
   
 
(284
)
   
 
(189
)
   
 
—  
 
   
 
(478
)
    
  
  
  
  
  
Total non-operating (income) expenses
   
 
23,366
 
   
 
(2,975
)
   
 
22,839
 
   
 
2,347
 
   
 
(21,171
)
   
 
24,406
 
    
  
  
  
  
  
Income (loss) before income taxes and extraordinary item
   
 
(21,869
)
   
 
2,822
 
   
 
(18,957
)
   
 
(534
)
   
 
21,171
 
   
 
(17,367
)
Provision for income taxes
   
 
3
 
   
 
122
 
   
 
1,100
 
   
 
275
 
   
 
—  
 
   
 
1,500
 
    
  
  
  
  
  
Income (loss) before extraordinary item
   
 
(21,872
)
   
 
2,700
 
   
 
(20,057
)
   
 
(809
)
   
 
21,171
 
   
 
(18,867
)
Extraordinary item
   
 
—  
 
   
 
3,005
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
3,005
 
    
  
  
  
  
  
Net loss
   
$
(21,872
)
   
$
(305
)
   
$
(20,057
)
   
$
(809
)
   
$
21,171
 
   
$
(21,872
)
    
  
  
  
  
  
 

14

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
Nine Months Ended September 30, 2002
(In thousands)
(Unaudited)
 
    
Parent Guarantor CPI
     
Issuer CP Int’l
     
Other Guarantors
     
Non- Guarantor China
     
Eliminations
     
Consolidated
  
Cash flows from operating activities:
                                                      
Net loss
   
$
(21,872
)
   
$
(305
)
   
$
(20,057
)
   
$
(809
)
   
$
21,171
 
   
$
(21,872
)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
                                                      
Depreciation and amortization
   
 
1,170
 
   
 
120
 
   
 
31,827
 
   
 
9,830
 
   
 
—  
 
   
 
42,947
 
Amortization of debt issuance cost
   
 
140
 
   
 
1,692
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
1,832
 
Non-operating early debt extinguishment loss
   
 
—  
 
   
 
3,005
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
3,005
 
Foreign currency (gains) loss
   
 
—  
 
   
 
—  
 
   
 
815
 
   
 
45
 
   
 
—  
 
   
 
860
 
(Gain) loss on sale of equipment
   
 
—  
 
   
 
—  
 
   
 
(78
)
   
 
13
 
   
 
—  
 
   
 
(65
)
Equity income from investment in subsidiaries
   
 
20,362
 
   
 
—  
 
   
 
809
 
   
 
—  
 
   
 
(21,171
)
   
 
—  
 
Changes in assets and liabilities:
                                                      
Intercompany accounts receivable
   
 
(144,546
)
   
 
13,682
 
   
 
(1,422
)
   
 
(7,671
)
   
 
139,957
 
   
 
—  
 
Accounts receivable
   
 
13
 
   
 
9
 
   
 
(5,838
)
   
 
(33
)
   
 
—  
 
   
 
(5,849
)
Inventories
   
 
—  
 
   
 
—  
 
   
 
(2,604
)
   
 
(948
)
   
 
—  
 
   
 
(3,552
)
Prepaid expenses and other current assets
   
 
(535
)
   
 
(38
)
   
 
(435
)
   
 
(579
)
   
 
—  
 
   
 
(1,587
)
Other assets
   
 
(95
)
   
 
(65
)
   
 
(6,588
)
   
 
(653
)
   
 
—  
 
   
 
(7,401
)
Intercompany accounts payable
   
 
510
 
   
 
110,072
 
   
 
26,975
 
   
 
2,400
 
   
 
(139,957
)
   
 
—  
 
Accounts payable
   
 
(109
)
   
 
(691
)
   
 
3,041
 
   
 
1,780
 
   
 
—  
 
   
 
4,021
 
Accrued expenses and other current liabilities
   
 
3,203
 
   
 
(7,351
)
   
 
2,873
 
   
 
1,248
 
   
 
—  
 
   
 
(27
)
Other long-term liabilities
   
 
—  
 
   
 
—  
 
   
 
4,796
 
   
 
—  
 
   
 
—  
 
   
 
4,796
 
    
  
  
  
  
  
Net cash provided by (used in) operating activities
   
 
(141,759
)
   
 
120,130
 
   
 
34,114
 
   
 
4,623
 
   
 
—  
 
   
 
17,108
 
    
  
  
  
  
  
Cash flows from investing activities:
                                                      
Acquisition of property, plant and equipment
   
 
(66
)
   
 
(3,837
)
   
 
(41,920
)
   
 
(12,176
)
   
 
—  
 
   
 
(57,999
)
Proceeds from sale of equipment
   
 
—  
 
   
 
—  
 
   
 
86
 
   
 
—  
 
   
 
—  
 
   
 
86
 
Malaysian acquisition, net of cash and cash equivalent acquired
   
 
—  
 
   
 
—  
 
   
 
(5,873
)
   
 
—  
 
   
 
—  
 
   
 
(5,873
)
Investment in subsidiaries
   
 
—  
 
   
 
—  
 
   
 
(7,507
)
   
 
—  
 
   
 
7,507
 
   
 
—  
 
    
  
  
  
  
  
Net cash used in investing activities
   
 
(66
)
   
 
(3,837
)
   
 
(55,214
)
   
 
(12,176
)
   
 
7,507
 
   
 
(63,786
)
    
  
  
  
  
  
Cash flows from financing activities:
                                                      
Proceeds from revolving loans and other line of credit
   
 
—  
 
   
 
100,000
 
   
 
5,596
 
   
 
—  
 
   
 
—  
 
   
 
105,596
 
Repayment of revolving loans and other line of credit
   
 
—  
 
   
 
(100,000
)
   
 
(5,596
)
   
 
—  
 
   
 
—  
 
   
 
(105,596
)
Proceeds from long-term debt
   
 
—  
 
   
 
—  
 
   
 
16,700
 
   
 
—  
 
   
 
—  
 
   
 
16,700
 
Intercompany loan payments
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
7,507
 
   
 
(7,507
)
   
 
—  
 
Debt issuance costs
   
 
—  
 
   
 
(703
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(703
)
Repayment of long-term debt
   
 
—  
 
   
 
(82,440
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(82,440
)
Repayment of notes from stockholders
   
 
505
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
505
 
Proceeds from common stock issuance
   
 
167,105
 
   
 
—  
 
   
 
  —  
 
   
 
—  
 
   
 
—  
 
   
 
167,105
 
Repurchase of non vested early exercise of stock options
   
 
(24
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(24
)
    
  
  
  
  
  
Net cash provided by (used in) financing activities
   
 
167,586
 
   
 
(83,143
)
   
 
16,700
 
   
 
7,507
 
   
 
(7,507
)
   
 
101,143
 
    
  
  
  
  
  
Net increase (decrease) in cash
   
 
25,761
 
   
 
33,150
 
   
 
(4,400
)
   
 
(46
)
   
 
—  
 
   
 
54,465
 
Cash and cash equivalents at beginning of period
   
 
1,842
 
   
 
17,093
 
   
 
20,939
 
   
 
1,998
 
   
 
—  
 
   
 
41,872
 
    
  
  
  
  
  
Cash and cash equivalents at end of period
   
$
27,603
 
   
$
50,243
 
   
$
16,539
 
   
$
1,952
 
   
$
—  
 
   
$
96,337
 
    
  
  
  
  
  

15

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS
December 31, 2001
(In thousands)
(Unaudited)
 
    
Parent
Guarantor
CPI
     
Issuer
CP Int’l
     
Other
Guarantors
     
Non-
Guarantor
China
     
Eliminations
     
Consolidated
  
ASSETS
                                                      
Current assets:
                                                      
Cash and cash equivalents
   
$
1,842
 
   
$
17,093
 
   
$
20,939
 
   
$
1,998
 
   
$
—  
 
   
$
41,872
 
Intercompany accounts receivable
   
 
59,103
 
   
 
85,860
 
   
 
20,347
 
   
 
12,166
 
   
 
(177,476
)
   
 
—  
 
Accounts receivable, net
   
 
30
 
   
 
11
 
   
 
31,961
 
   
 
32
 
   
 
—  
 
   
 
32,034
 
Inventories
   
 
—  
 
   
 
—  
 
   
 
9,682
 
   
 
2,799
 
   
 
—  
 
   
 
12,481
 
Prepaid expenses and other current assets
   
 
393
 
   
 
—  
 
   
 
3,527
 
   
 
595
 
   
 
—  
 
   
 
4,515
 
    
  
  
  
  
  
Total current assets
   
 
61,368
 
   
 
102,964
 
   
 
86,456
 
   
 
17,590
 
   
 
(177,476
)
   
 
90,902
 
Property, plant and equipment, net
   
 
6,054
 
   
 
—  
 
   
 
198,161
 
   
 
100,435
 
   
 
—  
 
   
 
304,650
 
Intercompany loans receivable
   
 
—  
 
   
 
352,500
 
   
 
—  
 
   
 
—  
 
   
 
(352,500
)
   
 
—  
 
Investment in subsidiaries
   
 
(40,002
)
   
 
—  
 
   
 
49,171
 
   
 
—  
 
   
 
(9,169
)
   
 
—  
 
Other assets
   
 
4,319
 
   
 
11,694
 
   
 
18,402
 
   
 
748
 
   
 
—  
 
   
 
35,163
 
    
  
  
  
  
  
Total assets
   
$
31,739
 
   
$
467,158
 
   
$
352,190
 
   
$
118,773
 
   
$
(539,145
)
   
$
430,715
 
    
  
  
  
  
  
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
                                                      
Current liabilities:
                                                      
Intercompany accounts payable
   
$
25
 
   
$
50,018
 
   
$
106,196
 
   
$
21,239
 
   
$
(177,478
)
   
$
—  
 
Revolving loans
   
 
—  
 
   
 
50,000
 
   
 
—  
 
   
 
—
 
   
 
—  
 
   
 
50,000
 
Accounts payable
   
 
2,181
 
   
 
749
 
   
 
21,615
 
   
 
6,500
 
   
 
—  
 
   
 
31,045
 
Accrued expenses and other current liabilities
   
 
2,759
 
   
 
11,417
 
   
 
7,829
 
   
 
5,833
 
   
 
—  
 
   
 
27,838
 
    
  
  
  
  
  
Total current liabilities
   
 
4,965
 
   
 
112,184
 
   
 
135,640
 
   
 
33,572
 
   
 
(177,478
)
   
 
108,883
 
Long-term debt, less current portion
   
 
—  
 
   
 
283,627
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
283,627
 
Convertible subordinated note
   
 
50,000
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
50,000
 
Intercompany loans payable
   
 
—  
 
   
 
—  
 
   
 
318,500
 
   
 
34,000
 
   
 
(352,500
)
   
 
—  
 
Other long-term liabilities
   
 
—  
 
   
 
—  
 
   
 
11,431
 
   
 
—
 
   
 
—  
 
   
 
11,431
 
    
  
  
  
  
  
Total liabilities
   
 
54,965
 
   
 
395,811
 
   
 
465,571
 
   
 
67,572
 
   
 
(529,978
)
   
 
453,941
 
    
  
  
  
  
  
Stockholders’ equity (deficit):
                                                      
Common stock
   
 
694
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
694
 
Additional paid in capital
   
 
110,043
 
   
 
81,689
 
   
 
16,907
 
   
 
108,133
 
   
 
(206,729
)
   
 
110,043
 
Receivable from stockholders
   
 
(985
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(985
)
Accumulated other comprehensive income
   
 
9,169
 
   
 
—  
 
   
 
8,705
 
   
 
464
 
   
 
(9,169
)
   
 
9,169
 
Accumulated deficit
   
 
(142,147
)
   
 
(10,342
)
   
 
(138,993
)
   
 
(57,396
)
   
 
206,731
 
   
 
(142,147
)
    
  
  
  
  
  
Total stockholders’ equity (deficit)
   
 
(23,226
)
   
 
71,347
 
   
 
(113,381
)
   
 
51,201
 
   
 
(9,167
)
   
 
(23,226
)
    
  
  
  
  
  
Total liabilities and stockholders’ equity (deficit)
   
$
31,739
 
   
$
467,158
 
   
$
352,190
 
   
$
118,773
 
   
$
(539,145
)
   
$
430,715
 
    
  
  
  
  
  

16

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
Nine Months Ended September 30, 2001
(In thousands)
(Unaudited)
 
    
Parent Guarantor CPI
     
Issuer CP Int’l
     
Other Guarantors
     
Non- Guarantor China
     
Eliminations
     
Consolidated
  
Revenue
                                                      
Intercompany revenue
   
$
18,427
 
   
$
—  
 
   
$
—  
 
   
$
41,800
 
   
$
(60,227
)
   
$
—  
 
Customer revenue
   
 
—  
 
   
 
—  
 
   
 
251,891
 
   
 
3
 
   
 
—  
 
   
 
251,894
 
    
  
  
  
  
  
    
 
18,427
 
   
 
—  
 
   
 
251,891
 
   
 
41,803
 
   
 
(60,227
)
   
 
251,894
 
Cost of revenue
   
 
—  
 
   
 
—  
 
   
 
247,847
 
   
 
39,068
 
   
 
(60,227
)
   
 
226,688
 
    
  
  
  
  
  
Gross profit
   
 
18,427
 
   
 
—  
 
   
 
4,044
 
   
 
2,735
 
   
 
—  
 
   
 
25,206
 
Operating expenses:
                                                      
Selling, general and administrative
   
 
13,740
 
   
 
198
 
   
 
9,063
 
   
 
2,600
 
   
 
—  
 
   
 
25,601
 
Research and development
   
 
3,370
 
   
 
—  
 
   
 
7,313
 
   
 
—  
 
   
 
—  
 
   
 
10,683
 
    
  
  
  
  
  
Total operating expenses
   
 
17,110
 
   
 
198
 
   
 
16,376
 
   
 
2,600
 
   
 
—  
 
   
 
36,284
 
    
  
  
  
  
  
Operating income (loss)
   
 
1,317
 
   
 
(198
)
   
 
(12,332
)
   
 
135
 
   
 
—  
 
   
 
(11,078
)
Non-operating (income) expenses
                                                      
Interest expense
   
 
—  
 
   
 
27,732
 
   
 
23,298
 
   
 
2,580
 
   
 
(25,877
)
   
 
27,733
 
Interest income
   
 
(33
)
   
 
(25,752
)
   
 
(372
)
   
 
(109
)
   
 
25,877
 
   
 
(389
)
(Income) loss from investment in subsidiaries
   
 
34,914
 
   
 
—  
 
   
 
2,367
 
   
 
—  
 
   
 
(37,281
)
   
 
—  
 
Foreign currency gains
   
 
—  
 
   
 
—  
 
   
 
(254
)
   
 
15
 
   
 
—  
 
   
 
(239
)
Other (income) expenses, net
   
 
(56
)
   
 
—  
 
   
 
(227
)
   
 
16
 
   
 
—  
 
   
 
(267
)
    
  
  
  
  
  
Total non-operating expense
   
 
34,825
 
   
 
1,980
 
   
 
24,812
 
   
 
2,502
 
   
 
(37,281
)
   
 
26,838
 
    
  
  
  
  
  
Loss before income taxes
   
 
33,508
 
   
 
2,178
 
   
 
37,144
 
   
 
2,367
 
   
 
(37,281
)
   
 
37,916
 
Provision for (benefit from) income taxes
   
 
113
 
   
 
371
 
   
 
(4,779
)
   
 
—  
 
   
 
—  
 
   
 
(4,295
)
    
  
  
  
  
  
Net loss
   
$
33,621
 
   
$
2,549
 
   
$
32,365
 
   
$
2,367
 
   
$
(37,281
)
   
$
33,621
 
    
  
  
  
  
  

17

Table of Contents
 
ChipPAC, Inc.
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
Nine Months Ended September 30, 2001
(In thousands)
(Unaudited)
 
    
Parent Guarantor CPI
     
Issuer CP Int’l
     
Other Guarantors
     
Non-Guarantor China
     
Eliminations
     
Consolidated
  
Cash flows from operating activities:
                                                      
Net loss
   
$
(33,621
)
   
$
(2,549
)
   
$
(32,365
)
   
$
(2,367
)
   
$
37,281
 
   
$
(33,621
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                                                      
Depreciation and amortization
   
 
1,362
 
   
 
—  
 
   
 
35,622
 
   
 
7,193
 
   
 
—  
 
   
 
44,177
 
Amortization of debt issuance cost
   
 
—  
 
   
 
1,522
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
1,522
 
Foreign currency (gains) loss
   
 
—  
 
   
 
—  
 
   
 
(256
)
   
 
17
 
   
 
—  
 
   
 
(239
)
Loss on sale of equipment
   
 
—  
 
   
 
—  
 
   
 
18
 
   
 
2
 
   
 
—  
 
   
 
20
 
Changes in assets and liabilities:
                                                      
Intercompany accounts receivable
   
 
(3,713
)
   
 
(39,072
)
   
 
5,289
 
   
 
(7,593
)
   
 
45,089
 
   
 
—  
 
Accounts receivable
   
 
7
 
   
 
(12
)
   
 
11,670
 
   
 
20
 
   
 
—  
 
   
 
11,685
 
Inventories
   
 
—  
 
   
 
—  
 
   
 
10,110
 
   
 
223
 
   
 
—  
 
   
 
10,333
 
Prepaid expenses and other current assets
   
 
143
 
   
 
—  
 
   
 
(8,609
)
   
 
1,146
 
   
 
—  
 
   
 
(7,320
)
Intercompany accounts payable
   
 
21
 
   
 
1,717
 
   
 
45,955
 
   
 
(2,604
)
   
 
(45,089
)
   
 
—  
 
Accounts payable
   
 
(26
)
   
 
55
 
   
 
(27,452
)
   
 
1,328
 
   
 
—  
 
   
 
(26,095
)
Accrued expenses and other current liabilities
   
 
(362
)
   
 
9,504
 
   
 
(29,702
)
   
 
607
 
   
 
—  
 
   
 
(19,953
)
Other long-term liabilities
   
 
666
 
   
 
—  
 
   
 
—  
 
   
 
(507
)
   
 
—  
 
   
 
159
 
    
  
  
  
  
  
Net cash provided by (used in) operating activities
   
 
(35,523
)
   
 
(28,835
)
   
 
10,280
 
   
 
(2,535
)
   
 
37,281
 
   
 
(19,332
)
    
  
  
  
  
  
Cash flows from investing activities:
                                                      
Acquisition of property, plant and equipment
   
 
(3,860
)
   
 
—  
 
   
 
(21,034
)
   
 
(9,082
)
   
 
—  
 
   
 
(33,976
)
Proceeds from sale of equipment
   
 
2,129
 
   
 
—  
 
   
 
(1,743
)
   
 
146
 
   
 
—  
 
   
 
532
 
Malaysian acquisition, net of cash and cash equivalents acquired
   
 
(4,546
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(4,546
)
Investment in subsidiaries
   
 
39,059
 
   
 
—  
 
   
 
(1,778
)
   
 
—  
 
   
 
(37,281
)
   
 
—  
 
    
  
  
  
  
  
Net cash provided by (used in) investing activities
   
 
32,782
 
   
 
—  
 
   
 
(24,555
)
   
 
(8,936
)
   
 
(37,281
)
   
 
(37,990
)
    
  
  
  
  
  
Cash flows from financing activities:
                                                      
Advances to affiliates
   
 
(19,341
)
   
 
6,479
 
   
 
3,427
 
   
 
9,435
 
   
 
—  
 
   
 
—  
 
Proceeds from revolving loans
   
 
18,714
 
   
 
(4,533
)
   
 
—  
 
   
 
(2
)
   
 
—  
 
   
 
14,179
 
Net proceeds from debt issuance
   
 
—  
 
   
 
60,703
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
60,703
 
Repayment of long-term debt
   
 
—  
 
   
 
(14,773
)
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(14,773
)
Proceeds from common stock issuance
   
 
4,271
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
4,271
 
    
  
  
  
  
  
Net cash provided by financing activities
   
 
3,644
 
   
 
47,876
 
   
 
3,427
 
   
 
9,433
 
   
 
—  
 
   
 
64,380
 
    
  
  
  
  
  
Net increase (decrease) in cash
   
 
903
 
   
 
19,041
 
   
 
(10,848
)
   
 
(2,038
)
   
 
—  
 
   
 
7,058
 
Cash and cash equivalents at beginning of period
   
 
181
 
   
 
(711
)
   
 
15,321
 
   
 
4,059
 
   
 
—  
 
   
 
18,850
 
    
  
  
  
  
  
Cash and cash equivalents at end of period
   
$
1,084
 
   
$
18,330
 
   
$
4,473
 
   
$
2,021
 
   
$
—  
 
   
$
25,908
 
    
  
  
  
  
  

18

Table of Contents
ITEM 2.
 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
All references are to ChipPAC’s fiscal quarters ended September 30, 2002 and September 30, 2001, unless otherwise indicated. This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “target,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and speak only as of their dates. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties, including those identified under Exhibit 99.1 filed with our annual report on Form 10-K for the year ended December 31, 2001 and other risks and uncertainties indicated from time to time in our filings with the SEC. Actual results could differ materially from these forward-looking statements. In addition, important factors to consider in evaluating these forward-looking statements include changes in external market factors, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors and various other competitive factors. In light of these risks and uncertainties, there can be no assurance that the matters referred to in the forward-looking statements contained in this quarterly report will in fact occur.
 
Results of Operations
 
Three and nine month periods ended September 30, 2002 compared to three and nine month periods ended September 30, 2001
 
Revenue.    Revenue was $94.7 million and $271.0 million in the three and nine month periods ended September 30, 2002, respectively, an increase of 26.8% and 7.6% compared to the three and nine month periods ended September 30, 2001, respectively. The increase in revenue is primarily due to growth in our Laminate and Test product lines as a result of a combination of higher end-market demand for our customers’ products and new customer and program wins since the same period last year. Unit volumes for the three and nine month periods ended September 30, 2002, increased 7.5% and 12.5% versus the prior year.
 
Gross Profit.    Gross profit during the three and nine month periods ended September 30, 2002 was $16.0 million and $43.3 million, respectively, an increase of 688.1% and 71.7% compared to the three and nine month periods ended September 30, 2001, respectively. Gross margin as a percent of revenue was 16.9% and 16.0% in the three and nine month periods ended September 30, 2002, as compared to 2.7% and 10.0% in the three month and nine month periods ended September 30, 2001. For the nine month period ended September 30, 2001, gross profit declined primarily as a result of lower end-market demand leading to lower equipment utilization as well as lower average selling prices. The actions taken by us, including reductions in work force and tight cost controls coupled with increased unit volume and higher equipment utilization contributed to the increased gross profit realized for the nine month period ended September 30, 2002. These results were reduced by the effect of higher gold prices and the appreciation of the South Korean Won against the United States Dollar when compared to the same periods in 2001 and a one-time payment to unionized employees in our South Korean plant in the nine month period ended September 30, 2002 with no comparable payment in 2001. Overall equipment utilization was approximately 63.0% for the three month period ended September 30, 2002 as compared to 55.0% in the same period in 2001.
 
Selling, General, and Administrative.    Selling, general and administrative expenses were $9.4 million and $29.0 million for the three and nine month periods ended September 30, 2002, respectively, which is an increase of 59.3% and 28.0% compared to the three and nine month periods ended September 30, 2001, respectively. The increase in expenses for the three month period was due to significant cost curtailments in the same period in 2001 that were not repeated in 2002. These included mandatory shut-down days, salary reductions, travel restrictions, and deferment of expenditures where the timing could be affected. In addition, we incurred additional expense for our various incentive programs for employees as a result of our improved results in the three and nine month periods ended September 30, 2002 compared to the same periods in 2001.
 
Research and Development.    Research and development expenses for the three and nine month periods ended September 30, 2002 were $2.6 million and $7.3 million, respectively, a decrease of 23.5% and 32.1% from the three and nine month periods ended September 30, 2001, respectively. Although we increased the number of research and development employees and internal resources in the three and nine month periods ended September 30, 2002 compared to the same periods in 2001, we were engaged in a significant project that required external spending during the 2001 periods. A comparable level of external spending was not required in the three and nine month periods ended September 30, 2002.
 
Restructuring and Other Costs.    We recorded expenses associated with reduction in work force and employee furlough costs of $3.0 million in the nine month period ended September 30, 2001 with no comparable costs in 2002.

19

Table of Contents
 
Interest Expense.    Total outstanding interest-bearing debt decreased to $317.9 million at September 30, 2002 compared to $362.0 million at September 30, 2001. The decrease in debt outstanding of $44.1 million from September 30, 2001 to September 30, 2002, was due to pay down of our term loans in the amount of $82.4 million, offset by an increase of our revolving line of credit of $21.6 million and an increase in foreign loans of $16.7 million. The decrease in debt was funded by our January 2002 and May 2002 public offerings. Related interest expense was $7.7 million and $24.5 million, for the three and nine month periods ended September 30, 2002, respectively, a decrease of 18.6% and 11.7% compared to the same periods ended September 30, 2001, respectively. The reduction in interest expense was due to reduced interest rates on our borrowings and reduced debt levels.
 
Foreign Currency Losses.    Net foreign currency gains were $0.5 million for the three month period ended September 30, 2002 and represented a $0.6 million increase from the same period in 2001, as compared to a net foreign currency loss for the nine month period ended September 30, 2002 of $0.9 million, which represents an increased loss of $1.1 million from the same period in 2001. These non-cash losses were primarily due to the fluctuations between the exchange rate of the United States Dollar and the South Korean Won related to long-term severance benefits payable to our South Korean employees in Korean Won.
 
Income Taxes.    Global Income tax expenses were $0.5 million and $1.5 million for the three and nine month periods ended September 30, 2002, respectively and we recorded a tax benefit of $ 0.0 and $4.3 million for the three and nine month periods ended September 30, 2001, respectively. In the fourth quarter of 2001, we recorded a valuation reserve that reversed previously recorded benefits in 2001 and previous years. We have a mix of tax rates across the various jurisdictions in which we do business, and our current estimated expense for 2002 is $2.0 million with $1.5 million recognized in the nine month period ended September 30, 2002. This estimate does not take into account any future benefit from loss carryforwards, which we may realize once we again achieve profitability.
 
Extraordinary Item.    A portion of the proceeds from our May 2002 public offering was used to extinguish term loan A and our capital expenditure loan and substantially pay down term loan B under our senior credit facilities. As a result, capitalized debt issuance costs of $3.0 million were written off and the charge was included in the results for the nine month period ended September 30, 2002 with no comparable results for the same period in 2001. There was no tax benefit for the write off because the costs were written off in a tax jurisdiction that provides no such benefit.
 
Net Loss.    As a result of the items above, net loss decreased to $3.2 million for the three months ended September 30, 2002, compared to net loss of $16.4 million for the three months ended September 30, 2001. Net loss decreased to $21.9 million for the nine months ended September 30, 2002, which includes an extraordinary loss of $3.0 million, as compared to $33.6 million for the nine months ended September 30, 2001.
 
Critical Accounting Policies
 
For critical accounting policies affecting us, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2001. Critical accounting policies affecting us have not changed materially since December 31, 2001.
 
Liquidity and Capital Resources
 
Our ongoing primary cash needs are for operations and equipment purchases. We spent $18.1 million and $58.0 million on capital expenditures during the three and nine month periods ended September 30, 2002, respectively, compared to $25.3 and $36.4 million in capital expenditures during the three and nine month periods ended September 30, 2001, respectively.
 
The terms of the acquisition of the Malaysian business require contingent incentive payments up to a maximum of $17.9 million through June 30, 2003. During the quarter ended September 30, 2002, we have paid $1.7 million relating to contingent incentive payments and cumulatively we have paid Intersil $12.7 million under this arrangement.
 
On January 30, 2002, we sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, we sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option at the public offering price for $6.00 per share. In connection with these sales, we received net proceeds of approximately $63.9 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.5 million was used for general corporate purposes.
 
On May 30, 2002, we sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with these sales, we received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans. The remaining $49.2 million was used for general corporate purposes.

20

Table of Contents
 
As of September 30, 2002, our total debt consisted of $317.9 million of borrowings, which was comprised of $165.0 million of senior subordinated notes, $36.2 million in term loans, $50.0 million in revolving loans, $16.7 million in foreign loans and $50.0 million of convertible subordinated notes. For the three month period ended September 30, 2002, these borrowings have weighted average interest rates of 12.8%, 6.1%, 7.3%, 4.3% and 8.0%, respectively.
 
Our total potential commitments on our loans, operating leases, Intersil incentive payments and restructuring reserve as of September 30, 2002, were as follows (in thousands):
 
    
Total
   
Within 1 Year
   
2–3 Years
   
4–5 Years
   
After 5 Years
On balance sheet commitments:
                                   
Senior credit facilities (term loan)
   
$
36,187
   
$
—  
   
$
—  
   
$
36,187
   
$
—  
Senior subordinated notes
   
 
165,000
   
 
—  
   
 
—  
   
 
—  
   
 
165,000
Convertible subordinated notes
   
 
50,000
   
 
—  
   
 
—  
   
 
—  
   
 
50,000
Line of credit and other loans
   
 
66,700
   
 
50,000
   
 
16,700
   
 
—  
   
 
—  
Restructuring
   
 
1,332
   
 
1,332
   
 
—  
   
 
—  
   
 
—  
    
  
  
  
  
Total on balance sheet commitments
   
 
319,219
   
 
51,332
   
 
16,700
   
 
36,187
   
 
215,000
    
  
  
  
  
Off balance sheet commitments:
                                   
Operating leases and rents
   
 
58,112
   
 
11,129
   
 
20,993
   
 
7,095
   
 
18,895
Contingent payments to Intersil (relating to purchase of Malaysian business)
   
 
5,205
   
 
5,205
   
 
—  
   
 
—  
   
 
—  
    
  
  
  
  
Total off balance sheet commitments
   
 
63,317
   
 
16,334
   
 
20,993
   
 
7,095
   
 
18,895
    
  
  
  
  
Total commitments
   
$
382,536
   
$
67,666
   
$
37,693
   
$
43,282
   
$
233,895
    
  
  
  
  
 
Our senior credit facilities, as amended, contain covenants restricting our operations and requiring that we meet specified financial tests. Our current financial tests for 2002 are as follows: (1) a requirement to raise at least $20.0 million in junior capital by March 1, 2002, which was fulfilled by us through an underwritten public offering of our Class A common stock in January 2002 and (2) a minimum EBITDA requirement based on a rolling 12 months ending June 30, 2002 and September 30, 2002, of $31.0 million and $37.0 million, respectively, with no requirement for December 31, 2002. Our actual 12 month EBITDA for the period ended September 30, 2002 was $59.0 million. There were no violations of the covenants under our senior credit facilities, as amended, through September 30, 2002. Beginning with the quarter ending December 31, 2002, the financial covenants will consist solely of a minimum interest coverage ratio and a maximum senior leverage ratio based on a rolling 12-months calculation.
 
During the quarter ended June 30, 2002, an assessment of approximately $13.2 million was made by the Korean National Tax Administration or NTA, relating to withholding tax not collected and remitted related to the loan between our subsidiaries in Korea and Hungary. Withholding on the transactions in question is not required by the prevailing tax treaty. There were no further assessments made during the quarter ended September 30, 2002. We have appealed the assessment through the NTA’s Mutual Agreement Procedure, or MAP, and believe that the assessment will be overturned. As of September 30, 2002, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a tax suspension of the proposed assessment until resolution of the disputed assessment. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. We complied with the guarantee request on August 1, 2002.

21

Table of Contents
 
We believe that our existing cash balances, cash flows from operations and available borrowings under our senior credit facilities provide sufficient cash resources to meet our projected operating and other cash requirements for the next twelve months. An event of default under any debt instrument, if not cured or waived, could have a material adverse effect on us. We may require capital sooner than currently expected. We cannot assure you that additional financing will be available when we need it or, if available, that it will be available on satisfactory terms. In addition, the terms of our senior credit facilities and senior subordinated notes significantly reduce our ability to incur additional debt. Failure to obtain any such required additional financing could have a material adverse effect on our company.
 
Other than the covenants on the debt as discussed above, we have no performance guarantees or unconsolidated entities. Our off-balance sheet commitments are limited to equipment operating leases, leases on office and manufacturing space and additional contingent incentive payments to Intersil. Our total off-balance sheet obligations are approximately $63.3 million.
 
For the nine month period ended September 30, 2002, cash provided by operations was $17.1 million and for the nine month period ended September 30, 2001, cash used in operations was $19.3 million. Cash provided by and used in operations mainly consisted of net loss plus depreciation and amortization less changes in working capital. During the nine month period ended September 30, 2002, $3.0 million, $1.8 million and $0.9 million from extraordinary items, debt issuance cost amortization and foreign currency loss, respectively, were added back to the net loss as these items do not require the outlay of cash.
 
For the nine month periods ended September 30, 2002 and 2001, cash used in investing activities was $63.8 million and $38.0 million, respectively. During the nine month periods ended September 30, 2002 and 2001, $58.0 million and $34.0 million were spent on capital expenditures, respectively. During the nine month periods ended September 30, 2002 and 2001, an additional $5.9 million and $4.5 million, respectively, was invested in the purchase of the Malaysian business, including purchased intellectual property.
 
For the nine month periods ended September 30, 2002 and 2001, cash provided by financing activities was $101.1 million and $64.4 million, respectively. For the nine month period ended September 30, 2002, $167.1 million was provided by the issuance of common stock and $16.7 million was provided by a bank loan and $100.0 million was provided by our revolver loan. We used $100.0 million to repay our revolver and $82.4 million to repay long-term debt. For the nine month period ended September 30, 2001, $50.0 million and $15.0 million was provided by the issuance of convertible debt and senior subordinated debt, respectively.
 
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
For quantitative and qualitative disclosures about market risks affecting us, see Item 7A “Quantitative Disclosure About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2001. Our exposure to market risks has not changed materially since December 31, 2001.
 
ITEM 4.    CONTROLS AND PROCEDURES
 
At the beginning of the third quarter, in response to recent legislation and additional requirements, we reviewed our internal control structure and our disclosure controls and procedures. As a result of such review we implemented minor changes, primarily to formalize and document the procedures already in place. We have designed our disclosure controls and procedures to ensure that material information related to ChipPAC, Inc. (including our consolidated subsidiaries) is made known to our disclosure committee, including our Chief Financial Officer, General Counsel and Chief Accounting Officer on a regular basis, in particular during the period in which the quarterly reports are being prepared. As required, we will evaluate the effectiveness of these disclosure controls and procedures on a quarterly basis, and did so within 90 days prior to the filing of this quarterly report. We believe as of that date, such controls and procedures were operating effectively as designed.
 
We presented the results of our most recent evaluation to our Audit Committee of the Board of Directors. Based on such evaluation, the Company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures are adequate to ensure the clarity and material completeness of the Company’s disclosures in its periodic reports required to be filed with the SEC and there are no significant deficiencies in the design or operation of internal controls which could significantly affect our ability to record, process, summarize and report financial data.
 

22

Table of Contents
 
PART II.    OTHER INFORMATION
 
ITEM 1.    LEGAL PROCEEDINGS
 
We are not involved in any legal proceedings, the outcome of which we believe would have a material adverse effect on our business, financial condition or results of operations. From time to time, however, we are involved in claims that arise in the ordinary course of business, and we maintain insurance that we believe to be adequate to cover these claims.
 
ITEM 2.    CHANGES IN SECURITIES AND USE OF PROCEEDS
 
Not applicable
 
ITEM 3.    DEFAULTS UPON SENIOR SECURITIES
 
Not applicable
 
ITEM 4.    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
Not applicable
 
ITEM 5.    OTHER INFORMATION
 
Not applicable
 
ITEM 6.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K
 
  2.1
   
Amended and Restated Agreement and Plan of Merger of ChipPAC, Inc., a California corporation, and ChipPAC, Inc., a Delaware corporation.**
  2.2
   
Agreement and Plan of Recapitalization and Merger, dated as of March 13, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
  2.3
   
First Amendment to Agreement and Plan of Recapitalization and Merger, dated as of June 16, 1999 by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
  2.4
   
Second Amendment to Agreement and Plan of Recapitalization and Merger, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
  3.1
   
Amended and Restated Certificate of Incorporation of ChipPAC, Inc.**
  3.2
   
Amended and Restated By-Laws of ChipPAC, Inc.**
  4.1
   
Specimen certificate for ChipPAC, Inc. Common Stock.**
10.1
   
Credit Agreement, dated as of August 5, 1999, as amended and restated as of June 30, 2000, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent.*
10.2
   
Guaranty, dated as of August 5, 1999, by and among ChipPAC, Inc. and certain subsidiaries of ChipPAC, Inc., in favor of Credit Suisse First Boston (incorporated by reference to Exhibit 4.5 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).
10.3
   
Amendment No. 1 to Amended and Restated Credit Agreement, dated as of March 13, 2001, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2002 (No. 000-31173)).
 

23

Table of Contents
10.4
   
Amendment No. 2 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001 (No. 000-31173)).
10.5
   
Amendment No. 3 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K (No. 000-31173)).
10.6
   
Amendment No. 4 to Amended and Restated Credit Agreement, as amended, dated as of May 17, 2002 by and among ChipPAC International Company Limited, ChipPAC, Inc, the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent.
10.7
   
Subsidiary Guaranty Agreement, dated as of August 5, 1999, by and among ChipPAC Korea Company Ltd., ChipPAC Limited, ChipPAC (Barbados) Ltd., ChipPAC Luxembourg S.a.R.L., ChipPAC Liquidity Management Hungary Limited Liability Company and ChipPAC International Company Limited, in favor of Firstar Bank of Minnesota, N.A.*
10.7.1
   
Subsidiary Guaranty Agreement, dated as of October 12, 2001, by ChipPAC Malaysia Sdn. Bhd, in favor of U.S. Bank, N.A.(incorporated by reference to Exhibit 4.7 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).
10.8
   
Amended and Restated Registration Agreement, dated as of August 5, 1999, by and among ChipPAC, Inc. the Hyundai Group (as defined therein), the Bain Group (as defined therein), the SXI Group (as defined therein), Intel Corporation, ChipPAC Equity Investors LLC, and Sankaty High Yield Asset Partners, L.P.*
10.8.1
   
Amendment No. 1 to Amended and Restated Registration Agreement, dated as of June 30, 2000, by and among ChipPAC, Inc., Sapphire Worldwide Investments, Inc., the Bain Stockholders (as defined therein) and SXI Group LLC.**
10.8.2
   
Form of Amendment No. 2 to Amended and Restated Registration Agreement, dated as of July 13, 2000, by and among ChipPAC, Inc., Qualcomm Incorporated, SXI Group LLC and the Bain Shareholders (as defined therein).**
10.8.3
   
Form of Amendment No. 3 to Amended and Restated Registration Agreement, dated as of August 2, 2000, by and among ChipPAC, Inc., Bain Capital, Inc., SXI Group LLC and the Bain Shareholders (as defined therein).**
10.9
   
Transition Services Agreement, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc., ChipPAC Korea Company Ltd., Hyundai Electronics Company (Shanghai) Ltd., ChipPAC Assembly and Test (Shanghai) Company Ltd., ChipPAC Barbados Limited and ChipPAC Limited.*
10.10
   
Lease Agreement, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.1
   
Amendment Agreement, dated September 30, 1998, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.2
   
Amendment Agreement 2, dated September 30, 1999, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.11
   
Agreement Concerning Supply of Utilities, Use of Welfare Facilities and Management Services for Real Estate, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.12
   
Service Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Limited.+*
10.13
   
Sublease Agreement, dated as of May 1, 1998, by and between Hyundai Electronics America and ChipPAC, Inc.*

24

Table of Contents
10.14
   
Patent Sublicense Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Limited.*
10.15
   
TCC License Agreement, dated December 22, 1998, between Tessera Inc., the Tessera Affiliates (as defined therein), ChipPAC, Inc. and the Licensee Affiliates (as defined therein).+*
10.15.1
   
Letter Agreement, dated July 15, 1999, by and among ChipPAC, Inc., Hyundai Electronics America, ChipPAC Limited and Tessera, Inc.*
10.16
   
Materials Agreement, dated as of July 1, 1999, by and between ChipPAC Limited and Intel Corporation.+*
10.17
   
Employment Agreement, dated as of October 1, 1999, between ChipPAC, Inc. and Dennis McKenna.*++
10.18
   
ChipPAC, Inc. 1999 Stock Purchase and Option Plan.*
10.19
   
ChipPAC, Inc. 2000 Equity Incentive Plan.**
10.20
   
ChipPAC, Inc. 2000 Employee Stock Purchase Plan.**
10.21.1
   
Form of Key Employee Purchased Stock Agreement.*
10.21.2
   
Form of Key Employee Purchased Stock Agreement (with Loan).*
10.22
   
Form of Employee Restricted Stock Agreement.*
10.23
   
Form of Directors Tranche I Stock Option Agreement.*
10.24
   
Form of Employees Tranche I Stock Option Agreement.*
10.25
   
Form of Tranche II Stock Option Agreement.*
10.26
   
Indenture, dated as of July 29, 1999, by and among ChipPAC International Limited, ChipPAC Merger Corp. and Firstar Bank of Minnesota, N.A., as trustee.*
10.27
   
First Supplemental Indenture, dated as of August 5, 1999, by and among ChipPAC International Company Limited, ChipPAC, Inc. and Firstar Bank of Minnesota, N.A., as trustee.*
10.28
   
12.75% Senior Subordinated Notes Due 2009.*
10.29
   
Form of Series B 12.75% Senior Subordinated Notes Due 2009.*
10.30
   
Intellectual Property Rights Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.31
   
Supply Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.32
   
Shareholders Agreement, dated as of June 30, 2000, by and among ChipPAC, Inc., the Bain Group (as defined therein), the SXI Group (as defined therein) and Sapphire Worldwide Investments, Inc.**
10.33
   
Class A Common Stock Purchase Agreement, dated as of July 13, 2000, by and between ChipPAC, Inc. and Qualcomm Incorporated.**
10.34
   
Promissory Note, dated as of August 2, 2000 by and between Dennis McKenna and ChipPAC, Inc.**
10.35
   
Promissory Note, dated as of August 2, 2000, by and between Robert Krakauer and ChipPAC, Inc.**
10.36
   
Employment letter agreement, dated as of November 15, 1999 between ChipPAC, Inc. and Robert Krakauer (incorporated by reference to the Company’s annual report on Form 10-K for the period December 31, 2000).

25

Table of Contents
 
  10.37
   
Employment letter agreement, dated as of March 18, 1998 between ChipPAC, Inc. and Gregory Bronzovic (incorporated by reference to the Company’s annual report on Form 10-K for the period December 31, 2000) .
  10.38
   
Employment letter agreement, dated as of October 4, 2000 between ChipPAC, Inc. and Richard Freeman (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
  10.39
   
Employment letter agreement, dated as of October 9, 2000 between ChipPAC, Inc. and Patricia McCall (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
  10.40
   
Indenture, dated as of June 15, 2001, by and between ChipPAC, Inc. and Firstar Bank, N.A. as trustee (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
  10.41
   
Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC International Company Limited and Citicorp Capital Investors Limited (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
  10.42
   
Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC, Inc. and Citicorp Mezzanine III, L.P. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
  10.43
   
Patent and Technology License Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries, Co., Ltd. and ChipPAC Limited (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
  10.44
   
License Agreement, dated as of February 1, 2001, by and between ChipPAC, Inc. and LSI Logic Corporation (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
  10.45
   
License Agreement, dated as of February 10, 2001, by and between ChipPAC, Inc. and LSI Logic Corporation (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
  10.46
   
License Agreement, dated as of August 27, 2001, by and between ChipPAC, Inc. and Fujitsu Limited (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
  10.47
   
Amendment to License Agreement, dated as of March 5, 2002, by and between ChipPAC, Inc. and Fujitsu Limited (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
  10.48
   
License Agreement, dated as of September 8, 1999, by and between ChipPAC Ltd. and LSI Logic Corporation (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
  10.49
   
Assembly/Final Test Subcontract Agreement, dated as of January 1, 2002, by and between ChipPAC Ltd. and its affiliates and Fairchild Semiconductor Corporation and its affiliates (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).+
21.1
   
Subsidiaries of ChipPAC, Inc., ChipPAC International Company Limited, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Liquidity Management Limited Liability Company, ChipPAC Luxembourg S.a.R.L. and ChipPAC Korea Company Ltd. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended on June 30, 2002).
99.1
   
Risk Factors (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
*
 
Incorporated by reference to the Company’s Form S-4 (No. 333-91641).
 
**
 
Incorporated by reference to the Company’s Form S-1 (No. 333-39428).

26

Table of Contents
 
 
+
 
Confidential treatment has been granted as to certain portions of these exhibits, which are incorporated by reference.
 
(b) Reports on Form 8-K.
 
    None

27

Table of Contents
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, as of November 13, 2002.
 
CHIPPAC, INC.
(Registrant)
/s/ Dennis McKenna        
DENNIS MCKENNA
Chief Executive Officer
 
/s/ Robert Krakauer        
ROBERT KRAKAUER
Chief Financial Officer
 
/s/ Michael G. Potter        
MICHAEL G. POTTER
Controller and Principal Accounting Officer

28

Table of Contents
 
CHIPPAC, INC.
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Dennis P. McKenna, the Chief Executive Officer of ChipPAC, Inc. (the “registrant”), certify that:
 
 
1.
 
I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2002 of the registrant;
 
 
2.
 
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
 
3.
 
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
 
4.
 
Robert Krakauer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
 
 
a.
 
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
 
b.
 
evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
 
c.
 
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
 
 
5.
 
Robert Krakauer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
 
 
a.
 
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
 
b.
 
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and
 
 
6.
 
Robert Krakauer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
 
November 13, 2002
 
/s/ Dennis P. McKenna         
Dennis P. McKenna
Chief Executive Officer

29

Table of Contents
 
CHIPPAC, INC.
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Robert Krakauer, the Chief Financial Officer of ChipPAC, Inc. (the “registrant”), certify that:
 
 
1.
 
I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2002 of the registrant;
 
 
2.
 
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
 
3.
 
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
 
4.
 
Dennis P. McKenna and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
 
 
a.
 
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
 
b.
 
evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
 
c.
 
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
 
 
5.
 
Dennis P. McKenna and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
 
 
a.
 
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
 
c.
 
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and
 
 
6.
 
Dennis P. McKenna and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
 
November 13, 2002
 
/s/ Robert Krakauer        
Robert Krakauer
Chief Financial Officer

30

Table of Contents
 
CHIPPAC, INC.
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Dennis P. McKenna, in my capacity as Chief Executive Officer of ChipPAC, Inc., a Delaware corporation (“ChipPAC”), and in connection with the Quarterly Report on Form 10-Q filed by ChipPAC with the Securities and Exchange Commission on November 13, 2002 (the “Report”), hereby certify that:
 
1.  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.
 
2.  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of ChipPAC.
 
IN WITNESS WHEREOF, the undersigned has executed this CEO Certification as of the 13th day of November, 2002.
 
/s/ Dennis P. McKenna         
Name:
  
Dennis P. McKenna
Title:
  
Chief Executive Officer

31

Table of Contents
 
CHIPPAC, INC.
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Robert Krakauer, in my capacity as Chief Financial Officer of ChipPAC, Inc., a Delaware corporation (“ChipPAC”), and in connection with the Quarterly Report on Form 10-Q filed by ChipPAC with the Securities and Exchange Commission on November 13, 2002 (the “Report”), hereby certify that:
 
1.  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.
 
2.  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of ChipPAC.
 
IN WITNESS WHEREOF, the undersigned has executed this CFO Certification as of the 13th day of November, 2002.
 
/s/ Robert Krakauer         
Name:
  
Robert Krakauer
Title:
  
Chief Financial Officer

32
EX-10.6 3 dex106.htm AMENDMENT NO.4 TO AMENDED AND RESTATED CREDIT AGMT. Amendment no.4 to Amended and Restated Credit Agmt.
Exhibit 10.6
 
 
CONFORMED COPY
 
 
AMENDMENT NO. 4, WAIVER AND AGREEMENT dated as of May 17, 2002 (this “Amendment”), to the CREDIT AGREEMENT dated as of August 5, 1999, as amended and restated as of June 30, 2000, and as amended by Amendment No. 1 dated as of March 13, 2001, Amendment No. 2 dated as of June 8, 2001 and Amendment No. 3 dated as of December 31, 2001 (the “Credit Agreement”), among CHIPPAC INTERNATIONAL COMPANY LIMITED, a British Virgin Islands company (the “Company”), CHIPPAC, INC., a Delaware corporation (“ChipPAC”), the Lenders (as defined therein) and CREDIT SUISSE FIRST BOSTON, a bank organized under the laws of Switzerland, acting through its New York branch (“CSFB”), as administrative agent for the Lenders (in such capacity, the “Administrative Agent”), as sole lead arranger and as collateral agent for the Administrative Agent and the Lenders.
 
A.    Pursuant to the Credit Agreement, the Lenders and the Issuing Bank have extended, and have agreed to extend, credit to the Company.
 
B.    ChipPAC has informed the Administrative Agent that it intends to issue and sell up to 13,800,000 shares of its Class A Common Stock in one or more underwritten registered public offerings on or prior to September 30, 2002 (collectively, the “Equity Offering”). The Company has informed the Administrative Agent that, upon the consummation of the Equity Offering, it desires to prepay the Term Loans by an amount equal to the lesser of (i) 50% of the Equity Proceeds thereof and (ii) $50,000,000, and that it desires to use up to $55,000,000 of the balance thereof to redeem and/or repurchase Subordinated Debt.
 
C.    ChipPAC and the Company have requested that the Required Lenders (as defined below) waive compliance by ChipPAC and the Company with certain provisions of the Credit Agreement, and that the Credit Agreement be amended, in each case as provided herein. The Required Lenders are willing to grant such waiver and to amend the Credit Agreement pursuant to the terms of subsection 10.6 of the Credit Agreement and subject to the terms and conditions set forth herein.
 
D.    Capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.
 
Accordingly, in consideration of the mutual agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1

 
SECTION 1.    Waivers.    (a)  The Required Lenders hereby waive compliance by ChipPAC and the Company with the provisions of subsection 2.4B(iii)(c) of the Credit Agreement to the extent necessary to allow ChipPAC or the Company to utilize the Equity Proceeds of the Equity Offering in accordance with Section 3 of this Amendment.
 
(b)  The Required Lenders hereby waive compliance by ChipPAC and the Company with the provisions of subsection 7.5 of the Credit Agreement to the extent necessary to allow the Company to use up to $55,000,000 of the Equity Proceeds of the Equity Offering (after prepaying the Term Loans as required by Section 3 of this Amendment) to redeem and/or repurchase Subordinated Debt (the “Subordinated Debt Redemption/Repurchase”).
 
SECTION 2.    Amendments to Credit Agreement.    (a)  Subsection 1.1 of the Credit Agreement is hereby amended as follows:
 
(i)  The definition of the term “Consolidated Excess Cash Flow” is hereby amended by deleting from clause (ii)(b) thereof the words “plus (or minus, if negative) the Carryforward for such period to be carried forward to the next period less the Carryforward (if any) for the preceding period carried forward to the current period.”
 
(ii)  The definition of the term “Excess Proceeds Amount” is hereby amended by deleting the text of clause (ii)(b) thereof and substituting therefor the words “[Intentionally Omitted].”
 
(iii)  The definition of the term “Leverage Ratio” is hereby amended and restated in its entirety as follows:
 
““Leverage Ratio” means, on any date, the ratio of (i) Consolidated Total Debt as of such date to (ii) Consolidated Adjusted EBITDA for the period of four consecutive fiscal quarters of the Company ended on such date (or, if such date is not the last day of a fiscal quarter, ended on the last day of the fiscal quarter of the Company most recently ended prior to such date).”
 
(iv)  The definition of the term “Pro Forma Compliance” is hereby amended by deleting the words “subsections 7.6A, B, C and D” therefrom and substituting therefor the words “subsections 7.6A, F and G.”
 
(v)  The defined terms “Acquired Capital Expenditures Percentage”, “Calculation Date”, “Carryforward”, “Fixed Charge Coverage Ratio” and “Maximum Consolidated Capital Expenditures Amount” are hereby deleted in their entirety.
 
(b)  Section 7 of the Credit Agreement is hereby amended as follows:
 
(i)  Subsection 7.3(iv) of the Credit Agreement is hereby amended by deleting therefrom the words “permitted by subsection 7.6D.”

2

 
(ii)  Subsection 7.6A of the Credit Agreement is hereby amended by deleting the table set forth therein and substituting therefor the following:
 
Period During Which
Calculation Period Ends
     
Minimum Interest Coverage Ratio
December 31, 2002 through June 30, 2003
     
1.50:1.0
September 30, 2003 through December 31, 2003
     
1.75:1.0
Thereafter
     
2.00:1.0
 
provided that, notwithstanding the foregoing, for each Calculation Period ending after the Term Loans have been repaid in full, the Interest Coverage Ratio for such period shall not be less than 1.50 to 1.0.
 
(iii)  Each of subsections 7.6B, C and D of the Credit Agreement is hereby deleted in its entirety and the words “[Intentionally Omitted]” substituted therefor.
 
(iv)  Subsection 7.6E of the Credit Agreement is hereby amended by (i) deleting the comma after the word “EBITDA” set forth therein and substituting therefor the word “and” and (ii) deleting the words “and Fixed Charges” therefrom.
 
(v)  Subsection 7.6F of the Credit Agreement is hereby amended and restated in its entirety as follows:
 
“F.    Maximum Senior Leverage Ratio.    The ratio (the “Senior Leverage Ratio”) of (i)(x)Consolidated Total Debt minus (y) to the extent included therein, the aggregate principal amount of Subordinated Debt and Convertible Subordinated Notes, as of the last day (any such day being a “Calculation Date”) of any Fiscal Quarter ending during any of the periods set forth below to (ii) Consolidated Adjusted EBITDA for the four-Fiscal Quarter period ending on such Calculation Date shall not exceed the correlative ratio indicated below:
 
Period During Which
Calculation Period Occurs
     
Maximum Senior Leverage Coverage Ratio
December 31, 2002 through September 30, 2003
     
1.75:1.0
Thereafter
     
1.50:1.0

3

 
provided that, notwithstanding the foregoing, for each Calculation Period ending after the Term Loans have been repaid in full, the Senior Leverage Coverage Ratio for such period shall not exceed 1.50 to 1.0.”
 
(vi)  Subsection 7.6G of the Credit Agreement is hereby amended and restated in its entirety as follows:
 
“G.    Minimum Consolidated Adjusted EBITDA.    The Consolidated Adjusted EBITDA for any four-Fiscal Quarter period ending on any date set forth below shall not be less than the corresponding amount set forth below opposite such date:
 
Date
     
Minimum Consolidated Adjusted EBITDA
June 30, 2002
     
$31,000,000
September 30, 2002
     
$37,000,000
 
SECTION 3.    Agreements.    (a)  The Company and ChipPAC hereby agree that, within one Business Day following receipt by ChipPAC or any of its Subsidiaries of any Equity Proceeds of the Equity Offering, the Company shall prepay outstanding Term Loans by an amount equal to the lesser of $50,000,000 and 50% of such Equity Proceeds, such prepayment to be applied as specified for mandatory prepayments in subsection 2.4C of the Credit Agreement.
 
(b)  The Required Lenders hereby agree that, to the extent not required to be used to prepay the Term Loans pursuant to this Section 3, the Equity Proceeds of the Equity Offering may be used by ChipPAC and the Company for any purpose permitted under the Credit Agreement, including to finance Permitted Acquisitions.
 
(c)  The Company, ChipPAC and the Required Lenders hereby agree that, the amount used to consummate the Subordinated Debt Redemption/Repurchase shall not be deemed to constitute Equity Proceeds for any purpose under clause (i)(b) of the definition of Excess Proceeds Amount.
 
SECTION 4.    Representations and Warranties.    To induce the other parties hereto to enter into this Amendment, the Company and ChipPAC represent and warrant to each of the Lenders that, after giving effect to this Amendment, (a) the representations and warranties set forth in Section 5 of the Credit Agreement are true and correct in all

4

material respects on and as of the date hereof, except to the extent such representations and warranties expressly relate to an earlier date, and (b) no Default or Event of Default has occurred and is continuing.
 
SECTION 5.    Effectiveness.    This Amendment shall become effective as of the date first written above (the “Amendment Effective Date”) on the date occurring on or prior to September 30, 2002, on which (a) the Administrative Agent shall have received (i) the Amendment Fees (as defined below) and (ii) counterparts of this Amendment that, when taken together, bear the signatures of the Company, the Guarantors, the Required Lenders and the Administrative Agent, and (b) the Equity Offering shall have been consummated and shall have generated not less than $50,000,000 of Equity Proceeds. As used herein, the term “Required Lenders” means (x) Lenders holding a majority of the outstanding principal amount of the Term Loans and (y) Lenders holding a majority of the Revolving Loan Commitments (whether used or unused).
 
SECTION 6.    Amendment Fee.    ChipPAC and the Company agree, jointly and severally, to pay to (a) each Lender that executes and delivers a copy of this Amendment to the Administrative Agent (or its counsel) at or prior to 5:00 p.m., New York City time, on May 17, 2002, an amendment fee in an amount equal to 0.375% of the sum of such Lender’s Revolving Loan Commitment (whether used or unused) and outstanding Term Loans, in each case as of the Amendment Effective Date, and (b) each other Lender that executes and delivers a copy of this Amendment to the Administrative Agent (or its counsel) after 5:00 p.m., New York City time, on May 17, 2002, but prior to 12:00 (noon), New York City time, on May 22, 2002 (the “Fee Payment Date”), an amendment fee, (together with the fees referred to in clause (a) above, the “Amendment Fees”) in an amount equal to 0.20% of the sum of such Lender’s Revolving Loan Commitment (whether used or unused) and outstanding Term Loans, in each case as of the Amendment Effective Date; provided that, solely for purposes of determining the Amendment Fees, the amount of the Term Loans actually outstanding as of the Amendment Effective Date shall be reduced by $50,000,000, such reduction to be allocated ratably among the outstanding Term Loans. The Amendment Fees shall be payable in immediately available funds on the Fee Payment Date, but only if the condition specified in Section 5(a)(ii) of this Amendment shall have been satisfied on or prior to the Fee Payment Date. Once paid, the Amendment Fees shall not be refundable.
 
SECTION 7.    Effect of Amendment.    Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of the Lenders, the Issuing Bank or the Administrative Agent under the Credit Agreement or under any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or in any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. Nothing herein shall be deemed to entitle any Loan Party to a

5

consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances. This Amendment shall apply and be effective only with respect to the provisions of the Credit Agreement specifically referred to herein. After the date hereof, any reference to the Credit Agreement shall mean the Credit Agreement, as modified hereby. This Amendment shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents.
 
SECTION 8.    Counterparts.    This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same contract. Delivery of an executed counterpart of a signature page of this Amendment by facsimile transmission shall be as effective as delivery of a manually executed counterpart hereof.
 
SECTION 9.    Applicable Law.    THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
 
SECTION 10.    Headings.    The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.
 
SECTION 11.    Acknowledgment of Guarantors.    Each of the Guarantors hereby acknowledges receipt and notice of, and consents to the terms of, this Amendment.

6

 
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their duly authorized officers, all as of the date and year first above written.
 
CHIPPAC INTERNATIONAL COMPANY LIMITED,
  by
  
/s/    Patricia H. McCall
   
Name:
  
Patricia H. McCall
   
Title:
  
Director
 
CHIPPAC, INC.,
  by
  
/s/    Patricia H. McCall
   
Name:
  
Patricia H. McCall
   
Title:
  
SVP Administration & GC
 
CHIPPAC KOREA COMPANY LTD.,
  by
  
/s/    Byeong Kynck Sohn
   
Name:
  
Byeong Kynck Sohn
   
Title:
  
President of ChipPAC Korea
 
CHIPPAC LIQUIDITY MANAGEMENT HUNGARY LIMITED LIABILITY COMPANY,
  by
  
/s/    Michael G. Potter
   
Name:
  
Michael G. Potter
   
Title:
  
Managing Director
 
CHIPPAC LUXEMBOURG S.A.R.L.,
  by
  
/s/    Gilles Jacquet
   
Name:
  
Gilles Jacquet
   
Title:
  
Director
  by
  
/s/    Johan Dejans
   
Name:
  
Johan Dejans
   
Title:
  
Director
 
CHIPPAC (BARBADOS) LTD.,
  by
  
/s/    Patricia H. McCall
   
Name:
  
Patricia H. McCall
   
Title:
  
Director

7

 
CHIPPAC LIMITED,
  by
  
/s/    Patricia H. McCall
   
Name:  
  
Patricia H. McCall
   
Title:
  
Director
 
CHIPPAC MALAYSIA SDN. BHD.,
  by
  
/s/    Ten Chin Bin
   
Name:  
  
Ten Chin Bin
   
Title:  
  
President & Managing Director
ChipPAC Malaysia Sdn. Bhd.
 
CREDIT SUISSE FIRST BOSTON, individually,
and as Administrative Agent and an Issuing Bank,
  by
  
/s/    Robert Hetu
   
Name:
  
Robert Hetu
   
Title:
  
Director
  by
  
/s/    Ian W. Nalitt
   
Name:
  
Ian W. Nalitt
   
Title:
  
Associate
 
ARK II CLO 2001-1, LIMITED,
By:
  
Patriarch Partners II, LLC
Its Collateral Manager,
  by
  
/s/    Lynn Tilton
   
Name:
  
Lynn Tilton
   
Title:
  
Authorized Signatory
 
BALANCED HIGH-YIELD FUND II, LTD.,
By:
   
ING Capital Advisors LLC,
as Asset Manager,
  by
   
/s/    Gordon Cook
    
Name:
  
Gordon Cook
    
Title:
  
Senior Vice President
& Portfolio Manager

8

 
BANK ONE, NA,
  by
  
/s/    Dennis Warren
   
Name:
  
Dennis Warren
   
Title:
  
First Vice President
 
CITIZENS BANK OF MASSACHUSETTS,
  by
  
/s/    Christopher G. Daniel
   
Name:
  
Christopher G. Daniel
   
Title:
  
Vice President
 
CSAM FUNDING I,
  by
  
/s/    Andrew H. Marshak
   
Name:
  
Andrew H. Marshak
   
Title:
  
Authorized Signatory
 
DEBT STRATEGIES FUND, INC.,
  by
  
/s/    Harsh Jaggi
   
Name:
  
Harsh Jaggi
   
Title:
  
Authorized Signatory
 
FIRST DOMINION FUNDING III,
  by
  
/s/    Andrew H. Marshak
   
Name:
  
Andrew H. Marshak
   
Title:
  
Authorized Signatory
 
FIRST SOURCE LOAN OBLIGATIONS TRUST,
By:
  
First Source Financial, Inc.
Its Servicer and Administrator,
  by
  
/s/    Kathi J. Inorio
   
Name:
  
Kathi J. Inorio
   
Title:
  
Senior Vice President
 
HELLER FINANCIAL INC.,
  by
  
/s/    Gregory Hong
   
Name:
  
Gregory Hong
   
Title:
  
Duly Authorized Signatory

9

 
IBM CREDIT CORP,
  by
  
/s/    Thomas S. Curcio
   
Name:
  
Thomas S. Curcio
   
Title:
  
Manager of Credit
 
INDOSUEZ CAPITAL FUNDING IV, L.P.,
By:
  
RBC Leveraged Capital, as Portfolio Advisor,
  by
  
/s/    Melissa Marano
   
Name:
  
Melissa Marano
   
Title:
  
Director
 
INDOSUEZ CAPITAL FUNDING VI, LIMITED,
By:
  
Indosuez Capital, as Collateral Manager,
  by
  
/s/    Charles Kobayashi
   
Name:
  
Charles Kobayashi
   
Title:
  
Principal and Portfolio Manager
 
J. H. WHITNEY MARKET VALUE FUND, L.P.,
  by
  
/s/    Michael B. DeFlorio
   
Name:
  
Michael B. DeFlorio
   
Title:
  
Managing Director
 
LONGHORN CDO (CAYMAN) LTD,
By:
  
Merrill Lynch Investment Managers, L.P.,
as Investment Advisor,
  by
  
/s/    Harsh Jaggi
   
Name:
  
Harsh Jaggi
   
Title:
  
Authorized Signatory

10

 
MAGMA CDO LTD.,
  by
  
/s/    Kaitlin Trinh
   
Name:
  
Kaitlin Trinh
   
Title:
  
Fund Controller
 
MERRILL LYNCH GLOBAL INVESTMENT SERIES: INCOME STRATEGIES PORTFOLIO,
By:
  
Merrill Lynch Investment Managers, L.P.,
as Investment Advisor,
  by
  
/s/    Harsh Jaggi
   
Name:
  
Harsh Jaggi
   
Title:
  
Authorized Signatory
 
MERRILL LYNCH PRIME RATE PORTFOLIO,
By:
  
Merrill Lynch Investment Managers, L.P.,
as Investment Advisor,
  by
  
/s/    Harsh Jaggi
   
Name:
  
Harsh Jaggi
   
Title:
  
Authorized Signatory
 
MERRILL LYNCH SENIOR FLOATING RATE FUND, INC.,
  by
  
/s/    Harsh Jaggi
   
Name:
  
Harsh Jaggi
   
Title:
  
Authorized Signatory
 
SANKATY HIGH YIELD ASSET PARTNERS, L.P.,
  by
  
/s/    Timothy Barns
   
Name:
  
Timothy Barns
   
Title:
  
Senior Vice President

11

 
VENTURE CDO 2002, LIMITED
By:
  
Its investment advisor, Barclays Capital Asset
Management Limited,
By:
  
Its sub-advisor, Barclays Bank PLC,
New York Branch,
  by
  
/s/    Michael G. Regan
   
Name:
  
Michael G. Regan
   
Title:
  
Director

12
-----END PRIVACY-ENHANCED MESSAGE-----